US20030135152A1 - Disposable cartridge for a blood perfusion system - Google Patents

Abstract

A disposable cartridge for use in extracorporeal blood perfusions systems that have a control unit for controlling the flow of fluids. The cartridge has a housing defining a plurality of internal passageways that connect to a cardiopulmonary circuit, a cardioplegia circuit and a suction circuit. The cartridge may be fitted with one or more of a bubble trap, a filter, and a valve.

Description

FIELD OF THE INVENTION
• This invention relates to blood perfusion systems. In particular, this invention relates to a disposable cartridge for the flow of fluids in a blood perfusion system.[0001]
BACKGROUND OF THE INVENTION
• In general, blood perfusion entails forcing blood through the vessels of a bodily organ. For such purposes, blood perfusion systems typically entail the use of one or more pumps in an extracorporeal circuit that is interconnected with the vascular system of a patient.[0002]
• Of particular interest, cardiopulmonary bypass surgery requires a perfusion system that provides for the temporary cessation of the heart to create a still operating field by replacing the function of the heart and lungs. Such isolation allows for the surgical correction of vascular stenosis, valvular disorders, and congenital heart defects. In perfusion systems used for cardiopulmonary bypass surgery, an extracorporeal blood circuit is established that includes at least one pump and an oxygenation device to replace the functions of the heart and lungs.[0003]
• More specifically, in cardiopulmonary bypass procedures oxygen-poor blood, i.e., venous blood, is gravity-drained or suctioned from a large vein entering the heart or other veins in the body (e.g., femoral) and is transferred through a venous line in the extracorporeal circuit. The venous blood is pumped to an oxygenator that provides for oxygen transfer to the blood. Oxygen may be introduced into the blood by transfer across a membrane or, less frequently, by bubbling oxygen through the blood. Concurrently, CO[0004]₂is removed across the membrane. The oxygenated blood is then returned through an arterial line to the aorta, femoral, or other artery.
• In addition to the above-noted components, extracorporeal fluid circuits used for cardiopulmonary bypass procedures also typically provide for the flow of a cardioplegia mixture through a cardioplegia line into the root of the aorta, coronaries and/or coronary sinus in order to nourish, arrest, and maintain the arrest of the heart. The cardioplegia mixture is typically circulated through a heat exchanger prior to patient delivery. Additional devices that can be employed include a reservoir to hold the venous blood, a heat exchanger to cool or heat the returned blood, and various filters to keep particles greater than a predetermined size from passage into the patient.[0005]
• Further, extracorporeal fluid circuits utilized during cardiopulmonary bypass procedures may also include various suction lines. Such lines are employed to remove blood that collects in the thoracic cavity during surgery. Such blood may contain debris such as skin, air, bone chips, etc. and may be salvaged via filtering and routed to a reservoir for subsequent washing and/or oxygenation and return to the patient. A vent line may also be utilized to remove blood that accumulates in the heart or vasculature (e.g., aortic root, pulmonary artery, etc.) during the bypass procedure. Removal of such accumulated blood may be important to avoid heart distention. The vented blood may be routed to a reservoir for subsequent oxygenation and return to the patient or washing. In addition to the above-noted components, extracorporeal fluid circuits utilized in connection with cardiopulmonary bypass procedures may include components for the introduction into the blood of various nutrients and pharmaceuticals.[0006]
• The various fluid circuitry and components of an extracorporeal circuit are set up by medical personnel prior to the bypass procedure. This can be a time consuming process since many of the connections are made by hand. As will be appreciated, this set-up procedure is also the source of potential error. Any incorrect or leaky connection can jeopardize both the success of the surgical procedure and the safety of the patient. Further, such an approach has entailed the separate setup and monitoring of each circuit by medical personnel during the course of a cardiopulmonary bypass procedure. Further, establishment of the operative interrelationships between the various circuits has been left to the attention and coordination of medical personnel. In view of the foregoing it would be desirable to have an integrated perfusion system which is easy to set-up, use and monitor during the bypass procedure. Such a system should eliminate many of the sources of error in the set-up, monitoring and use of conventional extracorporeal perfusion circuits as well as improve system monitoring and safety. The present invention comprises an integrated perfusion system which overcomes many of the disadvantages of present perfusion systems.[0007]
SUMMARY OF THE INVENTION
• In view of the foregoing, one objective of the present invention is to provide a blood perfusion system that provides for simplified set-up and interconnection/disconnection of various disposable components with monitoring/control components.[0008]
• Relatedly, another objective of the present invention is to provide a blood perfusion system that provides for both enhanced/simplified monitoring and control over various operating parameters during a medical procedure, and that concomitantly yields system performance advantages.[0009]
• Yet another objective of the present invention is to provide a blood perfusion system that readily provides medical personnel with information to facilitate setup and/or to facilitate operation, parameter monitoring and alarm response during perfusion procedures.[0010]
• An additional objective of the present invention is to provide a blood perfusion system that maintains a wide range of configurability for customized use by medical personnel on a patient-specific basis.[0011]
• One or more of the above-noted objectives and additional advantages are provided by the blood perfusion system disclosed herein. The system integrates one or more fluid lines and flow-through components in a disposable assembly that operatively interfaces with integrated fluid monitoring/flow control components of a control unit. Additional objectives and advantages may also be realized in the present invention via the provision of a multifunctional, graphic user interface that is operatively interconnected with fluid monitoring/flow control componentry in the disclosed system.[0012]
• In one aspect, this invention is a disposable cartridge for use in an extracorporeal blood perfusion system having a cardiopulmonary circuit for receiving venous blood from a patient, oxygenating the blood and returning the oxygenated blood to the patient, a cardioplegia circuit for delivering a cardioplegia solution to the patient, and a suction circuit for withdrawing blood or fluids from the patient or surgical site, the perfusion system having a control unit for controlling the flow of fluids in one or more of the circuits, the disposable cartridge comprising a housing defining a plurality of internal passageways, a first internal passageway being configured for connection to the cardiopulmonary circuit, a second internal passageway being configured for connection to the cardioplegia circuit and a third internal passageway being configured for connection to the suction circuit.[0013]
• The disposable cartridge may further comprise a filter configured for filtering fluid flowing through at least one of the plurality of internal passageways and/or a bubble trap configured for removing bubbles from fluid in at least one of the plurality of internal passageways. The housing may comprise a first rigid portion connected to a second flexible portion. The first portion may comprise a translucent material configured to allow viewing of fluid in the internal passageways. The disposable cartridge may further include at least one valve interconnected to at least two of the plurality of internal passageways, the valve being configured for selectively preventing fluid flow in at least one of the plurality of internal passageways. The housing may define a plurality of fluid inlet ports and outlet ports. The housing may further define an internal reservoir fluidly connected to at least one of the internal passageways.[0014]
• The disposable cartridge may further comprise a sample port configured for withdrawing a fluid sample from at least one of the plurality of internal passageways. The control unit of the perfusion system may include at least one fluid pressure sensor and the disposable cartridge may further include at least one pressure sensing station connected to at least one of the plurality of internal passageways, the pressure sensing station being configured to interface with the pressure sensor on the control unit through the flexible portion of the housing.[0015]
BRIEF DESCRIPTION OF THE DRAWINGS
• FIG. 1 illustrates a cardiopulmonary bypass system embodiment of the present invention.[0016]
• FIG. 2A illustrates one embodiment of a disposable assembly for use in the system embodiment of FIG. 1.[0017]
• FIG. 2B illustrates the disposable assembly of FIG. 2A[0018]
• FIG. 3A is a schematic diagram illustrating the interface between components of the disposable assembly and component interface region embodiments of FIGS. 2A and 2B, respectively.[0019]
• FIG. 3B is a schematic diagram illustrating the interface between components of an alternate embodiment of a disposable assembly and a corresponding alternate embodiment of a component interface region.[0020]
• FIG. 4 is a perspective view of the component interface region of the embodiment of FIG. 3A showing the cartridge, valve, arterial filter, and sensor interfaces.[0021]
• FIGS. 5A and 5B are perspective views of the venous entry module of FIGS. 3A and 3B; FIGS. 5C and 5D perspective views of the mounting bracket for the module of FIGS. 5A and 5B; FIG. 5E is a sectional view of the module of FIGS. 5A and 5B; and FIG. 5F is a cross sectional view along line F-F of the view of FIG. 5E.[0022]
• FIGS. 6A to[0023]6E are views of the venous line clamp.
• FIGS. 7A to[0024]7C are views of the venous reservoir bracket/mount
• FIGS. 8A to[0025]8E are views of the oxygenator mount/interface.
• FIGS. 9A to[0026]9F are views of the tubing clips.
• FIGS. 10A to[0027]10D are views of the cartridge cam locks and tabs.
• FIG. 11 is a block diagram of an alternative embodiment wherein the venous reservoir is connected to a vacuum source for use in vacuum assisted drainage procedures.[0028]
• FIG. 12 is a functional diagram of the continuous level sensor used to measure fluid level in the venous reservoir.[0029]
• FIG. 13 is a front perspective view of[0030]cartridge120.
• FIG. 14 is a front plan view of[0031]cartridge120.
• FIGS. 15 and 16 are right and left side views, respectively, of[0032]cartridge120.
• FIGS. 17 and 18 are top and bottom views, respectively, of[0033]cartridge120.
• FIGS. 19A and 19B are back plan and back perspective views, respectively, of[0034]cartridge120.
• FIG. 20A is a cross-sectional view of[0035]cartridge120 taken along line A-A of FIG. 19A.
• FIG. 20B is an enlarged view of detail B of FIG. 20A.[0036]
• FIG. 21 is a cross-sectional view of[0037]cartridge120 taken along line BB of FIG. 19A.
• FIG. 22 is a back plan view of[0038]cartridge120 with the flexible back layer removed.
• FIGS. 23A, 23B,[0039]24A and24B are partial views of a valve station incartridge120.
• FIG. 25 is a block diagram of the system architecture of the blood perfusion system of the present invention.[0040]
• FIG. 26 illustrates a schematic block diagram for the gas circuit shown in FIG. 25.[0041]
• FIGS.[0042]27 to33 illustrate various operational examples of one embodiment of thesystem user interface50. In particular, FIG. 27 illustrates the three display regions ofdisplay54 of the user interface.
• FIGS.[0043]28A-28F illustrate a variety of alarm and status messages displayed in the first region ofdisplay54.
• FIG. 29 illustrates information sets displayed in the second region of[0044]display54.
• FIGS.[0045]30A-30L illustrate various context-driven information sets and corresponding context-driven user control options displayed in the third region ofdisplay54.
• FIGS.[0046]31A-31F, FIGS.32A-32E and FIGS.33A-33F illustrate various features of context-drivenportion243.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
• The present invention is an integrated vertical perfusion system. The main components of the system are a console which houses the various pumps, control circuitry, sensors and other nondisposable hardware, and a disposable assembly which connects to and interfaces with the console. The disposable assembly includes all of the disposable components used in the extracorporeal blood circuit including, for example, a venous reservoir, a blood oxygenator, a heat exchanger and an arterial blood filter, as well as the tubing which connects the various components and which forms the extracorporeal blood flow path. The disposable assembly also includes a dedicated disposable cartridge which provides a primary interface between the disposable assembly and the console. The cartridge is provided with multiple fluid flow paths through which the various fluid circuits of the system flow. Sensors which interface with the fluid flow paths monitor certain characteristics of the system such as pressure, temperature, fluid level and the presence of bubbles in various locations in the system. These characteristics provide an indication of whether the system is operating within acceptable ranges. Should these monitored characteristics deviate from acceptable ranges the system is provided with feedback control features which cause the system to automatically return pressure, flow, and fluid levels back to safe and acceptable ranges. After any deviation, the system will alert the user and go into a safe mode if necessary/appropriate. The system will facilitate any required intervention by the user to return to safe and acceptable ranges.[0047]
• The perfusion system of the present invention will now be described. For purposes of clarity an overview of the system will first be provided. Then the various components and features of the system will be described including the disposable assembly and component interface, the system control, the user interface and an operational summary of the perfusion system.[0048]
• I. Perfusion System Overview[0049]
• FIG. 1 illustrates a[0050]perfusion system1 for use during cardiopulmonary bypass surgery. The system comprises one embodiment of various aspects of the present invention. Other applications and embodiments of the inventive aspects will be apparent to those skilled in the art.
• The[0051]system1 comprises a console orcontrol unit10 and adisposable assembly100.Disposable assembly100 is best seen in FIG. 2A which shows the disposable assembly prior to attachment to controlunit10. In the illustrated embodiment,control unit10 is “left-handed,” thereby permitting placement in an operating room so that it allows a user (e.g., perfusionist) to visually monitor thedisposable assembly100 when interfaced withcontrol unit10 during operations, and to readily maintain a direct line-of-sight with a head surgeon who is located in a sterile surgical field surrounding a patient table (not shown). In this regard, and by way of example only,control unit10 is provided withwheels5 and may be oriented at an angle relative to the patient table, as desired. As will be appreciated,control unit10 may also be designed to be “right-handed” or universal.
• [0052]Control unit10 includes various sensors and mounting hardware for supportably receiving and/or operatively interfacing withdisposable assembly100. More particularly, an uppercomponent interface plate12 shown in FIG. 4 includes acartridge interface region20 for receiving acartridge120 which forms a part ofdisposable assembly100. Thecartridge interface region20 includes various sensors for monitoring parameters of fluid flowing through thecartridge120 during use as will be explained in more detail hereafter. Further,control unit10 includes additional sensors for monitoring fluid parameters and various valves for controlling the flow of fluid throughdisposable assembly100.
• [0053]Control unit10 includes a plurality of vertically “stacked” roller pump assemblies31-36. Each pump assembly comprises arotatable control knob31a-36aand a pump information display3lb-36b, respectively.
• The[0054]control unit10 further includes one or more embedded processor(s) and auser interface50 having amain display54,user control knob52, and a back updisplay55.User interface50 may be incorporated into the main housing ofcontrol unit10 or may be provided in aseparate housing51 that it can be selectively interconnected at a desired height and angular orientation relative to anoutboard pole11 or other pole or mounting bracket located in a desired position oncontrol unit10 such as shown in FIG. 1. As will be further described,main display54 andbackup display55 ofuser interface50 may be provided with various graphic user interface (GUI) features, including touch-screen capabilities, which together withuser control knob52 may be selectively employed with the embedded processor(s) to establish/modify various settings for monitoring and controlling various parameters in a cardiopulmonary bypass procedure.
• In general, set-up of the[0055]system1 entails removal ofdisposable assembly100 from sterile packaging, e.g., a disposable tray, and positioning of the various components of thedisposable assembly100 relative to corresponding interfacing components ofcontrol unit10 as will be discussed in more detail hereafter. In general, three primary fluid flow circuits are defined by the disposable assembly100: a venous circuit (i.e., for receiving venous blood from a patient), an arterial circuit (i.e., for returning oxygenated blood to a patient) and a cardioplegia circuit (i.e., for delivery of cardioplegia to a patient). The arterial and venous circuits may be combinatively referred to as the arterial-venous, or “AV” circuit. Secondary circuits defined bydisposable assembly100 include two suction circuits (i.e., for selective suctioning of fluids from a patient by medical personnel), and a vent circuit (i.e., for venting accumulated blood or fluid from a patient's heart or vasculature). Another circuit comprising a fluid management or priming circuit is used prior to bypass to primedisposable assembly100. As will be further described, for flow control purposes through the fluid circuits, positioning of thedisposable assembly100 oncontrol unit10 includes the placement of various looped tubing lines within pump assemblies31-36 and positioning of various tubing lines into various valve assemblies oncontrol unit10.
• Additionally, for monitoring various parameters within the fluid circuits, the[0056]cartridge120 and various tubing lines and other components ofdisposable assembly100 are positioned in operative relationship to various pressure, temperature, bubble, fluid level, hematocrit, oxygen saturation and other sensors included incontrol unit10. Further, an oxygenation device and one or more heat exchangers included withindisposable assembly100 are connected to gas and/or fluid inlet/outlet ports oncontrol unit10. After initial connections are made between the disposable assemblies andcontrol unit10, the various fluid circuits defined by thedisposable assembly100 are primed (i.e., filled with liquid to remove air), according to predetermined protocols. Thereafter, various tubing lines may be interconnected to a patient to provide for the flow of fluids to/from the patient anddisposable assembly100.
• II. Disposable Assembly[0057]
• One embodiment of the[0058]disposable assembly100 is shown in FIGS. 2A and 2B.Disposable assembly100 comprises various extracorporeal blood circuit components interconnected by tubing to create a blood flow path. FIG. 2A is a view ofdisposable assembly100 before it is interfaced withcontrol unit10. FIG. 2B is similar to FIG. 2A except that the tubing has been removed to more clearly show the disposable components of the assembly. These disposable components includedisposable cartridge120,venous entry module108,pre-bypass filter168,venous blood reservoir106, a combined oxygenator andheat exchanger112, anarterial blood filter118 and tubing clips111a-111f. Note that although the oxygenator and heat exchanger are shown as an integrated unit, separate devices could be used as is known in the art. Thevenous entry module108,cartridge120 and tubing clips111 are unique to the perfusion system of the present invention and are discussed in more detail hereafter.
• III. Hardware Interface and Mounting Assemblies[0059]
• [0060]Control unit10 is provided with various structural elements including line clamps, sensors and mounting brackets for interfacing with components ofdisposable assembly100. Many of those sensors and interfacing structures are located on uppercomponent interface plate12 as seen in FIG. 4.Interface plate12 includes a cardioplegia-valve tubing block195.Tubing block195 includes a cardioplegiaair bubble sensor158, acardioplegia temperature sensor153 and a motorizedcardioplegia line valve96. Arterialvalve tubing block196 includes an arterial lineair bubble sensor126,arterial temperature sensor88,and a motorized arterialpatient line valve92. Venous entrymodule mounting bracket550 includes oxygen saturation-hematocrit standardization surface83,oxygen saturation-hematocritoptical sensor85 and avenous temperature sensor81.Interface plate12 includes a motorizedpre-bypass filter valve95 positioned abovevenous line clamp46 andpre-bypass filter mount70. Located at the bottom portion ofplate12 is an arterialfilter mounting arm760.
• Upper[0061]component interface plate12 includes a disposablecartridge interface region20.Interface region20 includes those components ofcontrol unit10 which interface directly withcartridge120.Cartridge mounting assembly21 is used to secure the cartridge toregion20 in a manner discussed hereafter with regards to FIGS.10A-10D.Region20 includes numerous pressure sensors for sensing line pressure in various circuit locations. These sensors include venousreservoir pressure sensor89, first suctionpump pressure sensor40, second suctionpump pressure sensor42, ventpump pressure sensor44, arterialline pressure sensor14, and cardioplegialine pressure sensor18. Each of these pressure sensors function in the same manner except that the sensors in the suction circuits sense negative pressure. Each sensor includes a load cell incontrol unit10 and a load cell stem or cylinder magnetically coupled thereto (not shown). The load cell stem is aligned with the cartridge at the location pressure is to be sensed. Pressure affects the vinyl backing of the cartridge causing a force to be exerted against the load cell stem. This force is converted to an electrical signal by the load cell. This electrical signal is then converted to a pressure by a microprocessor. An example of such a pressure sensor is described in U.S. Pat. No. 5,676,644 (Toavs et al.) which is incorporated herein by reference.
• A plurality of solenoid valve plungers are also included within[0062]region20. These valve plungers interface with complimentary valve structures withincartridge120 to open and close valves in various fluid circuits withincartridge120. These valve assemblies include cardioplegia bubbletrap purge valve404, vent pump tosequestration reservoir valve402, vent pump tovenous reservoir valve403, lowflow purge valve405, highflow purge valve406 and sequestration reservoir drain valve401. Additional valve assemblies could be included. For example, valve assemblies could be included from the suction pump to sequestration reservoir and/or suction pump to venous reservoir (not shown).
• [0063]Cartridge interface region20 includes several components which interface directly with a sequestration reservoir located withincartridge120. First and secondsequestration level sensors320 and322 are used to monitor the fluid level in the sequestration reservoir. Adefoamer push bar790 is used to apply pressure to a defoamer within the sequestration reservoir to ensure that fluid which enters the sequestration reservoir is caused to pass through the defoamer. Means is provided incontrol unit10 for bringing thecartridge120 into automatic operative engagement with the various components ininterface region20 by advancing such components throughplate12 into contact with the cartridge.
• At the upper portion of[0064]cartridge interface region20 are motorized priming solution (or other solution)bag line valves98 and cardioplegia crystalloidbag line valves99.Water connections147aand147bare provided for connecting to a cardioplegia heat exchanger.Water connections147aand147bare designed to mate withports149aand149boncardioplegia heat exchanger148 in a manner similar to that which will be described hereafter with respect to the water connections made to heat exchanger505 shown in FIGS.8A-8E
• [0065]Control unit10 includes additional structural elements for interfacing withdisposable assembly100. For example, the structure of thevenous entry module108 and the mounting bracket with which it is attached to controlunit10 are shown in FIGS.5A-5F. The structure and operation of the venous line clamps46 and the mounting bracket for thepre-bypass filter168 are shown in FIGS.6A-6E. The mounting bracket for the venous reservoir is shown in FIGS.7A-7B. The mounting hardware for the combined oxygenator/heat exchanger112 is shown in FIGS.8A-8E. The mounting hardware for thearterial filter118 is shown in FIGS. 1 and 4. The manner in whichcartridge120 is mounted and interfaced withcontrol unit10 is shown in FIGS.10A-10D. Finally, the structure of tubing clamps111a-111fis shown in FIGS.9A-9F. A discussion of these components and their mounting and interface withcontrol unit10 follows.
• Although certain sensors, valves, etc., are packaged together in blocks in this embodiment, they could be provided as individual components or combined together in any variety of integrated assemblies or in one common assembly.[0066]
• 1. Venous Entry Module[0067]
• The[0068]venous entry module108 is a unique component which allows multiple functions to be accomplished within a single circuit component. The structure and features of the venous entry module can best be understood with reference to FIGS. 5A and 5B. The manner in which the venous entry module is mounted and interfaced withcontrol unit10 is shown in FIGS.5C-5F.
• With particular reference to FIGS. 5A and 5B which are perspective views of the top and bottom portions of the venous entry module it can be seen that the venous entry module has inlet and[0069]outlet ports530 and532, respectively, which may be barbed.Housing534 defines a lumen or conduit between the inlet and outlet ports which comprises the primary flow passage for venousblood entering reservoir106. Asecondary flow port536 is provided allowing the flow through the venous entry module to be diverted through the pre-bypass filter during priming of thedisposable assembly100 as described more fully hereafter.Housing534 is also provided with sampling/infusion fluid addition/removal ports538,540 and542. These ports are connected to stopcockvalves539,541 and543, respectively. These valves allow access to the venous line for the addition of medication or fluids or removal of blood. For example, these valves allow a venous blood sample to be taken, allow fluids or drugs to be infused during the bypass procedure, allow blood to be removed for pre-donation sequestration prior to the procedure, and allow fluid to be added at some later point in the procedure. Mountingtabs544 and546 on the side portions ofhousing534 are located and sized to provide a handhold for easy loading and to ensure proper positioning of the venous entry module in upper and lower mountingclips548 and552 of mountingbracket550 as shown in FIGS. 5C and 5D.
• As shown in FIGS. 5B and 5C,[0070]housing534 includes an oxygen saturation-hematocrit sensing window554 and atemperature sensing window556.Window554 is aligned withoptical sensor85 on mountingbracket550 so that hematocrit and oxygen saturation of the venous blood flowing through the venous entry module can be measured. The manner of sensing oxygen saturation-hematocrit is described in detail in U.S. Pat. No. 5,356,593 (Heiberger et al.), the entirety of which is incorporated herein by reference.Window556 is aligned withinfrared temperature sensor81 to allow the temperature of the venous blood to be monitored. This temperature sensor is of conventional design and need not be described in detail herein.
• As best seen in FIGS. 5C and 5D the venous entry module is held in place in[0071]clips548 and552 byarms548a,548b,552aand552b. FIG. 5E is a front view ofvenous entry module108 inbracket550. FIG. 5F is a sectional view taken along line F-F of FIG. 5E. The distance between the adjacent arms is slightly less than the outer dimension of the portion of the venous entry module positioned between the arms. Therefore, the venous entry module is snap fit intobracket550 and held by the adjacent arms.Bracket550 includes ablock558 having a slidingportion560. Slidingportion560 is spring loaded by virtue of spring559 acting onstationary surface561.Portion560 includes a lower surface to which is mountedstandardization surface83. During power up prior to insertion of the venous entrymodule standardization surface83 is positioned oversensor85 to allow the sensor to automatically standardize at power up. The light reflects off the standardization surface which allows the device to standardize. As the venous entry module is installed, the sliding portion moves out of the way so thatwindow554 is positioned oversensor85.
• 2. Pre-Bypass Filter and Venous Line Clamp[0072]
• As noted above, the component interface region includes a venous line clamp assembly (VLC)[0073]46 for receivingtubing line104 therewithin and a bracket for mounting the pre-bypass filter to controlunit10. The tubing size of the portion ofline104 betweenVLC46 andvenous reservoir108 is preferably larger in diameter than the portion from the patient toVLC46. For example, the portion from the patient toVLC46 may be a one-half inch line while the portion from the VLC to the venous reservoir may be five-eighth inch. In general,VLC46 is provided to control the passage of venous blood from a patient to thevenous reservoir106 during bypass procedures. FIGS.6A-6E illustrate one embodiment of aVLC46, which comprises ahousing71 for receivingvenous tubing line104 through aslot72 provided in thehousing71. Alid73 may be hingedly interconnected tohousing71.Housing71 includes abracket70 into whichpre-bypass filter168 may be secured.Bracket70 is substantially cylindrically shaped and forms slightly more than 180° of the circumference of a cylinder. The dimensions of this cylindrical configuration are chosen so that the pre-bypass filter can be snap fit into the bracket and held without further attachment. Alid latch74 may be interconnected tohousing71, wherein alip portion74ais adapted for selectively retaininglid73 in a closed condition relative tohousing71. As will be appreciated, whenlid73 is in such a closed condition, avenous tubing line104 may be retained within theslot72 of thehousing71.
• The[0074]VLC46 further includes astepper motor75. One end of alead screw76 may be positioned in thestepper motor75 and the other end oflead screw76 may be interconnected to aplunger77, wherein thestepper motor75 may be selectively operated for advancement/retraction ofplunger77. Theplunger77 is sized and oriented to pass through an opening in the back of thehousing71, wherein selective operation of thestepper motor75 allows theplunger77 to be advanced across/retracted from theslot72 passing throughhousing71. By virtue of such selective ability to positionplunger77, theVLC46 provides for the selective occlusion of atubing line104 positioned within theslot72housing71. More particularly, whentubing line104 is positioned throughslot72 andlid73 is secured in a closed position by thelatch74, actual advancement ofplunger77 bystepper motor75 will cause thetubing line104 to be pinched betweenplunger77 andlid73 so as to occlude thetubing line104 to a desired, selective extent. Thelid73 can be opened at anytime, anywhere from the venous line clamp being fully open or closed. This allows removal of the venous line in the event of a failure so it can be manually clamped. Thelid73 is also clear so the user can verify venous line clamp actuation and open/closed status. In order to facilitate calibration at VLC46 (e.g., to accommodate varying wall thickness in tubing line104),VLC46 may further include anoptical encoder78, wherein a calibration procedure may be carried out to determine the desired positioning oflead screw76 for a given procedure.
• 3. Venous Reservoir[0075]
• The mounting assembly of[0076]venous reservoir106 is shown in FIGS. 7A and 7B. FIG. 7A is a perspective view ofreservoir mounting bracket602 spaced fromreservoir106 prior toreservoir106 being inserted intobracket602. FIG. 7B is a perspective view ofreservoir106 attached to mountingbracket602. For purposes of illustrating clearly the mountingstructure mounting bracket602 is shown detached fromcontrol unit10. During use it will be understood thatbracket602 is affixed to controlunit10 in the position shown in FIG. 1.
• As shown in FIGS. 7A and[0077]7B mounting bracket602 includesflexible arms604 and606. The arms are provided with grooves606aand604awhich are shaped to received the circumferential edge107aof alid107 at the top ofreservoir106.Reservoir106 is mounted by sliding edge107ainto grooves604aand606a.Flexible arms604 and606 are slightly curved and extend more than 180° around edge107aso thatreservoir106 is held in a snap fit configuration byarms604 and606.
• 4. Oxygenator/Heat Exchanger[0078]
• The mounting assembly for the combined oxygenator/heat exchanger is shown in FIGS.[0079]8A-8E. FIG. 8A is a perspective view of oxygenator/heat exchanger112 separated from mountingbracket500. FIG. 8B is a back perspective view of oxygenator/heat exchanger112 showing the location of the various gas and water inlet and outlet ports. FIG. 8C is a front view of mountingbracket500 showing the location of gas and water connections. FIG. 8D is a front view of the oxygenator/heat exchanger112 mounted onbracket500 and FIG. 8E is a cross-sectional view taken along line E-E of FIG. 8D.
• In the embodiment shown in FIGS. 8A and[0080]8B mounting assembly500 includes alower portion501 which is configured to receive the heat exchanger.Portion501 has a heatexchanger receiving slot502 withlower grooves502aand502b. Betweengrooves502aand502bis a ledge503 for retaining the heat exchanger. Slottedside portions504aand504bare configured to receive heatexchanger mounting tabs505aand505b. Thus, to mount oxygenator/heat exchanger112 onlower portion501 the heat exchanger505 is inserted inslot502 withheat exchangers tabs505aand505babove slottedside portions504aand504b. The heat exchanger is then moved in a downward direction so that the heat exchanger tabs mounting505aand505bare received inslots504aand504b, respectively, and so that retaining ledge503 is positioned between the heat exchanger and the oxygenator.
• As best seen in FIG.[0081]8C mounting assembly500 includesgas fittings508aand508bfor providing oxygen-containing gas to the oxygenator and removing carbon dioxide therefrom. Additionallyfittings509aand509bare provided for circulating heating/cooling fluid through the heat exchanger. Motorized oxygenatorvent line valve507 is provided to receivevent line105 connected between the oxygenator and venous reservoir. Loading of the vent line into the vent line valve is facilitated by ventline loading element506 which is slotted to receive and route the vent line throughslots507aand507bofvalve507.Valve507 includes aroller525 eccentrically mounted on a rotating member (not shown) that, when rotated, causes the roller to pinch the tubing to occlude or partially occlude flow.
• [0082]Fittings508a,508b,509aand509bare tapered at their end portions and have O-rings512,513,514 and515 disposed thereabout. The tapered ends offittings508aand508bare designed to sealingly engage gas inlet andoutlet ports518aand518bon the oxygenator while taperedfittings509aand509bare designed to sealingly engage water inlet andoutlet ports519aand519bof the heat exchanger. Mountingassembly500 is designed to automatically engage the tapered fittings with the corresponding ports of the oxygenator and heat exchanger. Mountingassembly500 includes astationary face plate510 and amoveable carriage member511. The carriage member may be advanced or retracted with respect to faceplate510 by operation of astepper motor516 acting on alead screw517 as shown in FIGS. 8A and 8E.
• The carriage member rides on guide rods (not shown) which are pressed into the face place. Forward and reverse limit switches (not shown) are used to indicate when the carriage member is forward or fully retracted. The carriage member must be retracted to load an oxygenator into the bracket.[0083]
• As best seen in FIG. 8E, the water and gas fittings are spring loaded along the fitting axes and able to move freely perpendicular to the axes. All of the fitting axes are parallel to allow them all to engage the oxygenator or heat exchanger in a single motion. Each fitting is mounted in a flanged bushing, such as[0084]520a,520b, and520c. The inside diameter of the bushing is larger than the outside diameter of the fitting at the inserted section, so that the fitting can move freely inside the bushing.
• Axial motion of the fitting relative to the bushing is prevented in one direction by a flange on the fitting (i.e.,[0085]521a,521b,521c) which mates with a flange on the bushing. Motion in the opposite direction is limited by a retaining ring (not shown) attached to the fitting which collides with the back surface of the bushing.
• The fitting assembly is spring loaded towards the mating port with a compression spring (i.e.,[0086]522a,522b,522c). The compression spring exerts a force on the back side of the bushing flange. The opposite end of the spring pushes against a surface of the fitting base which is fixedly attached to the carriage member.
• The heat exchanger water fittings are machined from a single piece of material. However, the gas supply fitting and scavenge line fitting are made from an assembly of a machined fitting piece and a standard pipe nipple. The pipe nipple rides inside the flanged bushing. The back portion of the gas fitting rides against the flange face of the flanged bushing.[0087]
• The gas and water fittings are connected to the carriage member so that they are caused to advance or retract by movement of the carriage member. Thus, once the heat exchanger has been mounted on[0088]lower portion501 the connections for water and gas may be automatically made by advancing the carriage so that the fittings are caused to engage with the corresponding ports on the oxygenator and heat exchanger.
• 5. Arterial Blood Filter[0089]
• The manner in which the[0090]arterial blood filter118 is mounted and interfaced withcontrol unit10 can best be understood with reference to FIGS. 1 and 4.Blood filter118 held by mountingarm760.Arm760 extends from a lower portion of uppercomponent mounting plate12.Arm760 includes a firststraight portion761 and a second flexiblecurved portion762.Curved portion762 is provided with agroove762awhich is sized to accommodate an outwardly extending lip on the cover offilter118.Curved portion762 is substantially semicircular and extends slightly past 180°. Therefore, the outwardly extending lip may be snapped into place ingroove762aso that the arterial filter is held securely byarm760.
• A rotating assembly means[0091]763 is activated during the priming ofdisposable assembly100 to causearm760 along witharterial filter118 to rotate 180°. This facilitates removal of air bubbles fromfilter118. By flipping thefilter 180° during an automated priming procedure, even though priming fluid follows an antegrade path through the filter from the inlet to the outlet the direction is from bottom to top. In conventional priming techniques retrograde flow of priming fluid from outlet to inlet is required in order to get bottom to top flow. In conventional systems, this requires extra set up for priming of the filter and a bypass line with extra ports.
• In order to enhance the efficiency of bubble removal during priming[0092]portion761 is angled about 221/2° from the horizontal andportion762 is angled about 45° from the horizontal to allow air to rise to the arterial filter purge outlet. This results infilter118 being held at an angle during bypass as shown in FIG. 1. However, during the priming procedure discussed in more detail hereafter, whenarm760 is rotated 180° theangled portions761 and762cause filter118 to be held such that its longitudinal axis is perpendicular to an intersecting horizontal plane. This allows priming fluid (and bubbles) to flow vertically and upwardly through the filter from the inlet to the outlet which lessens the chance of bubbles being trapped within the filter during priming.
• 6. Tubing Clips[0093]
• As indicated hereinabove, clips[0094]111a-fmay be provided to define predetermined U-shaped configurations fortubing loops110,132,140,178,180, and190, respectively. One embodiment that may be employed for tubing clips111a-fis illustrated in FIGS.9A-9F. As shown, theexemplary tubing clip700 may include acentral body member702 having twotubing connector wings704 extending from opposing sides of thecentral body member702. Each of thetubing connector wings704 may define a longitudinally-extending J-shaped channel for receiving a tubing length therethrough. One or more wedge-shapedmembers706 may be disposed within each of the J-shaped channels of thetubing connector wings704 for retaining tubing positioned through the channels. Alternatively, the tubing may be glued within the channels to prevent movement. Thetubing connector wings704 may be oriented at an angle relative to themain body member702 so that the center axis of each of the channels are angled. This allows the tubing entering the pump to conform to the pump raceway. This allows a desired tubing loop configuration to be formed when the clip is applied to the tubing thus facilitating the loading of the tubing loop into one of the pump assemblies3136. Thecentral body member702 may include a projectinggrip tab708 contoured in an hourglass configuration to facilitate handling and placement of theclip700 in a pump assembly. In the latter regard, the central body member may include a hollow bottom portion to matingly fit over a projection provided on a pump assembly. Theclip700 may be integrally formed (e.g., via molding, etc.). The tubing clips may be color coded to match corresponding color coding oncontrol unit10 to ensure correct placement of the pump loops.
• 7. Cartridge[0095]
• The[0096]perfusion cartridge120 allows for automation of the perfusion system because the compact and standardized format of the positioning of the passageways in thecartridge120 allows computer controlled sensors and actuators to interact with thecartridge120. It is important that the interface betweencartridge120 andcontrol unit10 be precise and secure. The manner in whichcartridge120 is mounted oncontrol unit10 is shown in FIGS. 10A and 10D. In this regard,cartridge mounting assembly21 secures theperfusion cartridge120, as shown in FIG. 10A, tocartridge interface region20.Interface region20 contains temperature and/or pressure sensors located to interface mount with sensor stations on thecartridge120.Region20 also contains valve plungers positioned to interface with valve stations on the cartridge.
• FIG. 10A shows[0097]cartridge120 contained within mountingassembly21. Althoughinterface region20 and mountingassembly21 are part of uppercomponent interface plate12 for purposes of illustration and to facilitate an understanding of the mounting ofcartridge120 only mountingassembly21,interface region20 andcartridge120 are shown in FIGS.10A-10A-D.
• FIG. 10C shows[0098]cartridge120 spaced apart from mountingassembly21. To facilitate mountingcartridge120 is provided with mountingtabs121.Assembly21 hasopenings115 which exposeslots117 which are sized to securely accepttabs121 ofcartridge120. To loadcartridge120 into mountingassembly21tabs121 are aligned withopenings115. The cartridge is then moved in the direction ofinterface region20 until thetabs121 align withslots117. Once so aligned the cartridge is moved downward in the direction of arrow131 (FIG. 10D). This secures each of the tabs in corresponding slots and holdscartridge120 againstinterface region20.
• To insure that[0099]cartridge120 is properly positioned with respect tointerface region20 and that it maintains the proper position during the bypass procedure a positioning mechanism is provided. As shown in FIG. 10B, which is an enlarged portion of FIG. 10A, motorized cardioplegiacrystalloid valves99 include anangled bottom surface124. Whencartridge120 is loaded into mountingassembly21valves99 are retracted so that they do not extend beyond the surface ofinterface region20. Oncecartridge120 has been loaded into mountingassembly21 the continuing set up of the system results invalves99 being advanced past the surface ofinterface region20 until they reach the position shown in FIG. 10B. As the valves advance angledsurface124 abuts againstsurface127 oncartridge120 resulting in a downward pressure being exerted oncartridge120. This ensures thatcartridge120 is in its proper position and that it does not move during the bypass procedure.
• [0100]Valves99 are roller valves similar in structure tovalve507 and include rollers101 andslots99aand99b.Valves98 are roller valves similar tovalves99 although the specific structure is not shown in FIG. 10B. The cartridge includestubing retainers102a-dwhich hold the crystalloid solution and priming lines in the proper alignment for loading tovalves98 and99.
• IV. Functional Integration of Disposable Assembly and Control Unit[0101]
• FIGS. 3A and 3B are schematic diagrams of different embodiments of the functional interface between[0102]disposable assembly100 andcontrol unit10. The embodiment of FIG. 3A relates to the functional interface of a system using thecartridge120 as disclosed in the drawing figures herein. The embodiment of FIG. 3B relates to a version of the perfusion system using a cartridge modified in a manner disclosed herein.
• As shown in FIG. 3A,[0103]disposable assembly100 includes a number of tubing lines that either alone or in combination with the integral passageways ofcartridge120 define a number of fluid circuits. In particular,tubing line104 extends from a cannula assembly at a distal end (not shown) to avenous reservoir106 via avenous entry module108. As previously described the venous entry module includes sensingwindows554 and556 which interface with oxygen saturation-hematocrit sensor85 andtemperature sensor81 located incartridge interface region20. These sensors can provide feedback for use in various control circuits. For example, a user can set alarm limits which provide an alarm if a low oxygen saturation and/or hematocrit condition exists. Further, if oxygen saturation is low the system can be set to automatically increase the speed of thearterial blood pump31 an incremental amount and/or automatically adjust the gas blender to increase gas flow or FiO₂concentration through the oxygenator, until the condition is corrected. Additionally, when blood is detected as flowing through the venous entry module bysensor85 all pre-bypass activity is automatically inhibited (i.e.,pre-bypass filter valve95 is closed so that flow through the pre-bypass filter is discontinued). The venous entry module also allows pre-donation blood to be collected for reinfusion to the patient at the end of the procedure through alarge bore stopcock543 on the front of the venous entry module. Pre-donation is the collection of a portion of the patients blood, usually about one liter but is based on calculating what the patient can give up without lowering the hematocrit below some predetermined value, as the blood first comes down the venous line. This blood is sequestered and usually reinfused back into the patient at the end of the procedure.
• For purposes hereof, all components upstream of[0104]oxygenator112 collectively comprise the “venous circuit”. During a cardiopulmonary bypass procedure,tubing line104 will transfer venous blood from one or more of the large veins entering the heart (e.g., the venae cava) or other veins of a patient tovenous reservoir106. As described with respect to FIGS.6A-6E, the flow of venous blood thoughline104 may be selectively regulated by a venous line clamp (VLC)46. Flow may also be regulated by using a vacuum system interconnected to thevenous reservoir106 as discussed hereafter with respect to FIG. 11, or a pump (not shown) that regulates venous blood flow throughline104 upstream of thevenous reservoir106. The VLC is an integral part in the automatic control of the perfusion system. Once the bypass has been initiated the VLC is automatically kept open whenarterial pump31 is running. Ifpump31 shuts down for any reason the VLC may automatically be closed by the system control. The VLC may be closed when the level sensor in the venous reservoir senses that the reservoir is full. Additionally, the rate of flow of blood to the venous reservoir can be controlled by the extent to whichline104 is occluded by the VLC. The control can be automatic such as a system initiated response due to a high blood level condition being sensed in the venous reservoir, or can be manual through user settings at the user interface.
• [0105]Tubing line104 may be constructed from a clear, flexible tubing to allow for selective occlusion by theVLC46 and to otherwise allow for visual inspection of fluid passage therethrough by a user. In this regard, theVLC46 may include atransparent lid73.
• [0106]Reservoir106 may be of a hard shell or soft, plastic construction, and may be partially transparent with volumetric markings to facilitate visual monitoring of volume content by a user during a bypass procedure. Thereservoir106 may include a gas vent at a top end thereof to allow for the venting of any accumulated gas. Alternatively, the reservoir may be sealed, and may further include a top port for interconnection with a vacuum source for optional use in vacuum assisted venous drainage procedures. The vacuum source may comprise a vacuum pump (e.g., within control unit10) or a regulator that may be selectively interconnected with a facility vacuum line.
• FIG. 11 shows an alternative embodiment where[0107]reservoir106 is connected to a vacuum source for use in vacuum assisted drainage procedures. In FIG. 11,vacuum line721 is attached to the vacuum port ofvenous reservoir106, connecting the venous reservoir to the vacuum system. The system comprisesvacuum line721 interconnected to floatvalve722,hydrophobic filter726,electronic vacuum regulator727, and to anexternal vacuum source728. Thefloat valve722 automatically closes to prevent fluid from entering the vacuum system in the event of a venous reservoir overflow. Thehydrophobic filter726 also prevents fluid from passing further into the vacuum system. Theelectronic vacuum regulator727 provides continuously adjustable control of the vacuum level in the venous reservoir as measured byvacuum sensor725, and as discussed hereafter, can be activated to provide level control within the venous reservoir. Also incorporated in the vacuum circuit are positivepressure relief valve723 and excessvacuum relief valve724. These valves will automatically open if required to provide additional control to prevent vacuum from exceeding a predetermined upper or lower limit.
• The venous reservoir can be provided with a[0108]level sensor87 as will be described in more detail hereafter with respect to FIG. 12. The sensed level can be used to activate alarms at the user interface indicative of, for example, full reservoir, empty reservoir, and low level. The sensed level can also be used in the closed loop feedback control of other parts of the perfusion system which affect the level of blood in the reservoir. For example, the sensed level can be used to control the fluid level in the reservoir by controlling VLC occlusion, arterial pump speed or the amount of vacuum if the reservoir is vacuum assisted in order to maintain, increase or decrease the reservoir volume or level as needed to transfer fluid back and forth to the patient or maintain a safe reservoir level to prevent emptying.
• A reservoir[0109]filter pressure sensor89 is included inintegral passageway164 in the embodiment of FIG. 3A. During bypass if suctioned cardiotomy blood is routed to the venous reservoir the reservoir filter can clog. This cardiotomy blood is gravity drained from the sequestration reservoir and if the venous reservoir filter becomes clogged, pressure can build.Sensor89 senses the increased pressure from a clogged filter and provides an alarm onuser interface50. In the event of any alarm, the suction and vent pumps may be stopped and/or valve401 may be automatically closed, and/orvalve98 may be automatically closed.
• Connected to the bottom end of[0110]reservoir106 is aninterconnect tubing line110 which carries blood fromvenous reservoir106 to anoxygenator112. Although referred to herein asoxygenator112 it should be understood that the oxygenator may include an integral heat exchanger. As will be further described, the flow of blood through theinterconnect tubing line110 is selectively regulated byarterial pump31.Tubing line110 may include aclip111aas described with respect to FIGS.9A-9F for retaining a predetermined tubing length in a predetermined u-shaped configuration for ready interface with thearterial pump assembly31. Further, such clip may be color-coded (e.g., red for arterial) and configured to facilitate ready pump interface identification and clip placement during loading procedures.
• [0111]Pressure sensor84 may be provided to sense the pressure intubing loop110 downstream of thearterial pump31 and upstream of theoxygenator device112. In this regard, the monitored pressure may be compared to predetermined minimum and maximum values. A monitored pressure below the predetermined minimum value indicates thatpump31 may not be occludingtubing loop110 as desired or may not otherwise be operating at a rate set by use ofcontrol31a, resulting in an alarm/indication atinterface50. A monitored pressure that exceeds the predetermined maximum value indicates that the arterial circuit downstream ofsensor84 may be undesirably occluded (e.g., partially or fully), and may effect automated stoppage or slow down ofpump31 and result in an alarm/indication atinterface50.
• [0112]Oxygenation device112 is fluidly interconnected at its outlet port tooutlet tubing line116 which is connected to the inlet ofarterial filter118.Outlet tubing line116 may be retainably positioned relative to abubble sensor114 located oncontrol unit10.Bubble sensor114 serves several functions. First, if bubbles are detected an alarm may be activated atuser interface50. Second, detected bubbles may cause an auto air shunt feature to be activated as described in more detail hereafter.
• The embodiment of FIG. 3A includes an oxygenator[0113]vent tubing line105 from the oxygenator to the venous reservoir.Tubing line105 passes throughoxygenator vent valve507.Vent valve507 has several functions. First, it is automatically opened during priming to remove air from the oxygenator and is closed after a predetermined time. Second, it can be manually opened by the user during bypass if, for example, the venous reservoir emptied causing air to enter the system necessitating that the system be reprimed or, repriming the oxygenator after oxygenator replacement.
• [0114]Arterial filter118 is designed to filter particles greater than a predetermined size (e.g., having a maximum cross-sectional thickness greater than 50 microns), and is fluidly interconnected tooutlet tubing lines122,128, and119a.Outlet tubing line122 is provided for the return of oxygenated blood to a patient via a cannula assembly at a distal end (not shown).Tubing line122 may be retainably positioned in abubble sensor126 located oncontrol unit10. If bubbles are sensed bysensor126 an alarm atuser interface50 will be activated. Additionally, a signal will be fed to thecontrol unit10 which will cause thearterial pump31 to stop. The system is designed so that anytime the arterial pump is stopped, purgevalves405 and406 and the arterialpatient valve92 may be closed. It should be noted that anytime a detected alarm condition causes the system to automatically stop a pump or close a valve that action can be overridden by the user at the user interface.
• In the event a user would like to draw a sample of the blood passing through[0115]arterial filter118, a user may open astopcock valve310 or311 provided oncartridge120. If the sample is to be taken fromvalve310, eithervalves405 or406 must be open. For purposes of hemoconcentration, a user may also manuallyopen valve310 or311 provided oncartridge120 to provide for the flow of arterial blood therethrough. In this regard, the user may provide a separate hemoconcentrator unit (not shown) having inlet tubing connected to stopcockvalve310 or311 and outlet tubing interconnected to a transfer bag (not shown) or interconnected to an inlet port provided atvenous entry module108 orvenous reservoir106.
• For purposes hereof, the noted components downstream from[0116]oxygenator112 throughoutlet tubing line122 collectively, comprise the “arterial circuit”. To facilitate priming procedures,tubing lines104 and122 may be initially fluidly connected via aconnector175 which is removed after priming and prior to cannula placement.
• In order to monitor the temperature of the oxygenated blood returned to a patient, the upper[0117]component interface plate12 may also includetemperature sensor88 located intubing line122. Alternatively, thesensor88 may be positioned for sensing temperatures atarterial filter118. The monitored temperature of returned blood is compared to predetermined minimum/maximum range values, wherein an alarm or other indication (e.g., an indication of potential responsive action) can be provided atuser interface50 upon the detection of out-of-range conditions. Similarly,valve assembly92 may be included to receivetubing line122 downstream of thebubble sensor126, and may be selectively and automatically opened/closed to control the flow of oxygenated blood throughtubing line122, including for example, closure both during pre- or post-bypass procedures and whenbubble sensor126 detects gaseous bubbles in the oxygenated blood during bypass procedures.
• [0118]Tubing lines119aand119bare provided for fluid flow fromarterial filter118 tocartridge120, and fromcartridge120 toreservoir106, respectively. Adjoining integral passageways309aand309bare provided incartridge120 to selectively receive fluid flowing throughtubing line119a. In order to control the flow of fluid through passageways309aand309b,cartridge interface region20 includesinterface valve assemblies405 and406. When opened,valve405 provides for a relatively low flow rate through passageway309b.Valve406 provides for a relatively high flow rate through passageway309awhenvalve406 is open. During bypass procedures,valves405 and406 typically remain open and closed, respectively; providedpressure sensor14 senses a pressure greater than a predetermined minimum value. If a pressure lower than the minimum value is sensed bothvalves405 and406 automatically close in order to prevent air from being sucked from the venous reservoir into the arterial filter. A user may selectively change these states viauser interface50, as will be further described. In order to purge air fromtubing line116 and arterial filter118 (e.g., upon bubble sensing by bubble sensor114),valve92 may be closed (e.g., automatically), andvalves405 and406 may be opened (e.g., automatically), wherein blood will flow throughtubing line119a, integrated passageway spurs309aand309b, and tubing line119bintovenous reservoir106 via an inlet port. Additionally, in the event that air is detected intubing line122,valves92 and96 may be closed andvalve404 opened so as to cause blood to flow retrograde from the patient throughtubing line122 throughfilter118, flowtubing line128,integral passageway130 and ultimately throughintegral passageways164 and308 for return tovenous reservoir106 throughline129. It should be noted thatvalve406 may be selectively opened for recirculation purposes or otherwise by a user.
• As noted,[0119]arterial filter118 is also interconnected tooutlet tubing line128, which in turn is interconnected with one end of anintegral passageway130 defined within thecartridge120 to provide the blood supply for the cardioplegia system.
• [0120]Pressure sensor14 is provided incartridge interface region20 for monitoring the fluid pressure withinfluid passageway130 andtubing lines128 and122 fluidly interconnected thereto. During cardioplegia blood delivery viatubing line128 and pump35, the monitored pressure may be compared to a predetermined value to insure that an adequate blood delivery pressure is provided. If the pressure falls below a predetermined minimum value, pump35 may be stopped and/or an alarm/indication may be provided atuser interface50. Additionally, if the arterial blood circuit has become occluded, automated stoppage ofpump31 may be provided and an alarm/indication may be provided atuser interface50 if the pressure exceeds a predetermined maximum value.
• [0121]Tubing line128,cartridge passageway130 andtubing loop132 are provided for the flow of blood therethrough for selective downstream mixture with a heart-arresting solution (e.g., a cardioplegic crystalloid solution) and/or a substrate enhancing solution (e.g., nutritional solution) in anintegral passageway142 ofcartridge120. As will be further described,tubing loop132 interfaces with a cardioplegiablood pump assembly35 ofcomponent interface region12 to control mixture ratios.Tubing loop132 may include a clip111bto establish the desired unshaped configuration for the pump interface, and the clip may be color-coded (e.g., red) to facilitate ready loading.
• [0122]Disposable assembly100 further includes one or morespiked tubing lengths133 for interconnection between one or morecorresponding bags136 of a heart-arresting solution (e.g., crystalloid solution) and afluid passageway138 integrally defined withincartridge120. One or more substrate enhancing solutions (not shown) may also be fluidly interconnected byspiked tubing lengths133 to theintegral passageway138 ofcartridge120. Whenmultiple bags136 are provided they may contain solutions of different concentration and/or ingredients. The user is able to select the desired solution concentration by selecting at the user interface which one ofvalves99 is opened. The user is able to select a volume or time bolus of solution and the openedvalve99 automatically closes when delivery is completed or interrupted such as when one or more ofpumps31,35 or36 is stopped. The user is also able to manually select and deliver the cardioplegia solution.
• [0123]Passageway138 is interconnected to atubing loop140 that flows heart-arresting or substrate enhancing solution out of and back into thecartridge120 and interfaces therebetween with apump assembly36 oncontrol unit10 that regulates the flow rate through thetubing loop140.Tubing loop140 may include aclip111cto establish the desired u-shaped configuration for pump interface, and theclip111cmay be color-coded to facilitate loading.
• [0124]Integral passageway142 is also interconnected to the above-mentionedtubing loop132 for establishing a desired mixture between the cardioplegic crystalloid solution and blood pumped into theintegral passageway142. In this regard, it should be appreciated that cardioplegia provided to a patient may comprise predetermined (or dynamically adjusted) relative amounts of a heart-arresting solution (crystalloid) and blood, and may alternatively comprise only a heart-arresting solution (crystalloid), or alternatively comprise only oxygenated blood.
• In this regard, a[0125]tubing line146 is provided for the passage of a cardioplegia solution out of thecartridge120, through acardioplegia heat exchanger148 and abubble trap152, and back into thecartridge120. In an alternate arrangement,heat exchanger148 and/orbubble trap152 may be integrated intocartridge120.
• Of additional note, the embodiment of FIG. 3A includes a[0126]stopcock valve302 in fluid communication with thebubble trap152 through which the cardioplegia mixture flows during operations. The inclusion ofstopcock valve302 allows a user to selectively infuse drugs into the cardioplegia mixture. Further,stopcock valve302 may be selectively employed by a user for interconnection of an auxiliary pressure sensor (i.e., monitor the cardioplegia pressure) or it can be used to sample the cardioplegia solution or can be connected to a hemoconcentrator (not shown). Relatedly, it is noted that thecartridge120 in the FIG. 3A embodiment also includes an addedintegral passageway308 that interfaces with acorresponding valve assembly404 provided in thecartridge interface region20. More particularly,valve404 can be selectively opened/closed in opposing or same relation tovalve96 in a number of situations. For example,valve96 may be closed andvalve404 opened during priming so as to cause fluid flowing throughintegral passageway150 to flow throughintegral passageway308 and intointegral passageway164. Additionally, during cardioplegia delivery, if a user observes a build-up of gas inbubble trap152, a user may openvalve404, thereby causing at least some fluid to be diverted throughintegral passageway308 intointegral passage164, thereby purging the air frombubble trap152. If the fluid pressure is too low to effect purging,valve404 may be automatically closed to prevent the introduction of air into the circuit.
• At its downstream end,[0127]tubing line146 is connected frombubble trap152 to anotherintegral passageway150 ofcartridge120. In the embodiment disclosed thebubble trap152 andcardioplegia heat exchanger148 are combined in a single unit which is separate fromcartridge120 but that fits into the cartridge and interfaces directly withcontrol unit10 atcartridge interface region20.Bubble trap152 may be equipped with a bubble sensor (not shown) that, upon sensing bubbles would causecardioplegia purge valve404 to open andcardioplegia patient valve96 to close thus routing the cardioplegia solution to the venous reservoir throughline164. Air bubbles may be manually purged frombubble trap152 by activation of a button (not shown) onuser interface50.Bubble trap152 may include a filter screen (e.g., a 200 micron screen) to trap particulates and air and may include a vent (e.g., a one-way valve) having a hydrophobic membrane.
• [0128]Pressure sensor18 is provided incartridge interface region20 to sense the pressure withinpassageway150. During cardioplegia delivery the monitored pressure may be compared with a predetermined maximum value to identify if the cardioplegia circuit has become occluded (e.g., wherein automated stoppage ofpumps36 and/or35 may be effected and an alarm/indication may be provided at interface50). Additionally, the pressure may be monitored during cardioplegia delivery to insure an adequate cardioplegia delivery pressure. In the event the monitored pressure falls outside of user set limits an alarm/indication may be provided atinterface50 and/or the speed of one or both ofpumps35 and36 is either increased or decreased in order to maintain the desired pressure. For example, the user may set at the user interface a high pressure limit of 150 mmHg, a low pressure limit of 20 mmHg and a control point of 100 mmHg. By utilizing the monitored pressure as a feedback control parameter the system will automatically adjust the speed of the pumps to maintain pressure at the control point. If the pressure exceeds for any reason the upper or lower limit an alarm is activated at the user interface.
• A[0129]temperature sensor153 is provided incardioplegia valve block195 to monitor the temperature of the fluid inline156. High and low temperature alarm limits may be set by the user at the user interface and if those limits are exceeded an alarm is activated atuser interface50.
• Additionally, if the pressure sensed by[0130]cardioplegia line sensor18 is below the minimum limit the system automatically causes either or both thecardioplegia patient valve96 andcardioplegia purge valve404 to close. This prevents retrograde air from being introduced into the cardioplegia circuit throughpatient tube line156, cardioplegia sample/infusion valve302 orcardioplegia purge line308.Integral passageway150 is interconnected totubing line156 having a catheter assembly (not shown) at its distal end for the delivery of the cardioplegia mixture to a patient.
• [0131]Tubing line156 may be fluidly interconnected viatubing connector175 totubing line104 and122 for priming purposes, whereintubing line156 is disconnected fromtubing connector175 after priming.Tubing line156 may be retainably positioned incardioplegia valve block195 containing acardioplegia patient valve96, atemperature sensor153, and abubble sensor158 provided in the uppercomponent interface plate12, as described. If bubbles greater than an acceptable size are detected atsensor158 the system automatically stops one or both ofpumps35 and36 and provides an alarm atuser interface50. For purposes hereof, the above-described components that provide for the flow of blood fromtubing line128 and crystalloid solution frombags136, throughtubing line156, collectively comprise the “cardioplegia circuit”.
• For priming purposes and/or adding blood or other solutions,[0132]disposable assembly100 further includes one or more spikedtubing line lengths160 for interconnection between one ormore bags162 of priming fluid or other solutions and afluid passageway164 integrally defined withincartridge120. An outlet offluid passageway164 is interconnected to a filtered inlet ofreservoir106. Relatedly, it is also noted that thedisposable assembly100 includes atubing spur166 interconnected with thevenous entry module108 of the component interface region for the selective passage of priming fluid therethrough during priming operations. Further in this regard, tubing spur166 includes apre-bypass filter168 for filtering the priming solution to ensure that particles having a size greater than a predetermined value (e.g., greater than 5 microns) are filtered from the system prior to the initiation of bypass procedures. During priming flow is automatically directed throughpre-bypass filter168 by closingVLC46 and openingpre-bypass filter valve95. Since the pores of the pre-bypass filter are very fine and would be clogged by blood, as soon as the presence of blood is sensed atsensor85 of the venousentry module valve95 is closed and theVLC46 is opened thus routing the blood directly to thevenous reservoir106.
• For purposes of priming and for filtering in conjunction with priming,[0133]valve assembly95 is provided to receivetubing line166 for selective and automatic closure/opening. Similarly,valve assembly96 is provided to receivecardioplegia tubing line156 and is selectively and automatically operable for opening/closure, including for example, automatic closure upon detection of gaseous bubbles in the cardioplegia mixture bybubble sensor158. One ormore valve assemblies98 are also provided incomponent interface region12 for automatically and selectively controlling the flow of priming solution from one or morepriming solution bags162 through tubing line(s)160. Similarly, one ormore valve assemblies99 are provided for selectively and automatically controlling the flow of crystalloid solution from the one or morecrystalloid solution bags136 through tubing line(s)133.
• The[0134]disposable assembly100 also includes first and secondtubing suction lines170 and172, respectively, each of which are interconnectable at their distal ends to corresponding suctioning devices (not shown) for removing fluid from a patient surgical site. The first andsecond tubing lines170,172 are initially plugged at the end to allow leak testing, occlusion testing of the suction pumps32 and34 and testing to ensure that the pump loops are loaded in the pumps in the correct direction. Each ofsuch tubing lines170 and172 are interconnected to correspondingintegral passageways174 and176, respectively, within thecartridge120, which passageways are in turn interconnected withtubing loops178 and180, respectively.
• [0135]Pressure sensors40 and42 are provided incartridge interface region20 to monitor the pressures withinsuction tubing lines170 and172, respectively, which are interconnected withpassageways174 and176, respectively. In this regard, the monitored pressures may be compared with a predetermined negative pressure value (e.g., corresponding with a risk of blood trauma or tissue damage or indicating that a suction wand is occluded against tissue), wherein automated stoppage ofpump32 or34, respectively, may be effected upon detection of a pressure that is below the predetermined negative pressure value and an alarm/indicator may be otherwise provided atinterface50. A positive pressure may indicate that a pump is operating in reverse wherein automated stoppage ofpumps32 and34 may be effected upon detection of that positive pressure and an alarm indicator may be otherwise provided atuser interface50. Further, the user may set at the user interface a high pressure limit and a low pressure limit and a desired control point therebetween. The monitored pressure is used as a feedback control parameter to automatically adjust pump speed (32 or34) to maintain pressure at the control point.
• [0136]Tubing loops178 and180 interface withsuction pumps32 and34 in thecomponent interface region12 to provide for the desired suction. Thetubing loops178 and180 may be provided withclips111dand111ethat define the desired unshaped configuration for the pump interface. Each ofsuch clips11 id,111e, may be color-coded (e.g., yellow for suction) and otherwise configured to facilitate loading of thetubing loops178 and180. The downstream ends oftubing loops178 and180 are interconnected tointegral passageways182 and184 ofcartridge120, which passageways182,184 are in turn each fluidly interconnected with theintegral passageway185 for the passage of suctioned blood tosequestration reservoir301.
• [0137]Disposable assembly100 may also include a thirdsuction tubing line186 having a cannula assembly for interconnection with the left ventricle or vasculature of a patient's heart so as to provide for the venting of blood or fluid that may accumulate therewithin. The thirdsuction tubing line186 may initially be plugged at the end to allow leak testing, occlusion testing of thesuction pump33, and testing to ensure that thepump loop140 is loading inpump33 in the correct direction.Tubing line186 is interconnected to aninternal passageway188 ofcartridge120 which in turn is interconnected totubing loop190.Pressure sensor44 is provided to monitor the pressure within thesuction line186 which is interconnected with thepassageway188. Again, the monitored pressure may be compared to predetermined negative and positive pressure values, as previously described with respect tosuction lines170 and172, wherein automated stoppage ofpump33 may be effected upon detection of a pressure that is below the predetermined negative pressure value or above the positive pressure value and an alarm/indication may be provided atinterface50 upon detection of an out-of-range condition (e.g., either above the positive pressure value or below the negative pressure value).
• It should be noted that[0138]pressure sensors40,42 and44 function in a manner similar tosensors14 and18 except that they measure both negative and positive pressure values.Tubing loop190 interfaces with thevent pump33 provided incomponent interface region12 to provide the desired suction intubing line186, as will be further described.Tubing loop190 may be provided with aclip111fto define a predetermined unshaped configuration for pump interface. Theclip111fmay be color-coded (e.g., green) and otherwise configured to facilitate loading. The downstream end oftubing line190 is interconnected to an internal passageway192 which, in turn, splits into two passageways192aand192b. Flow through these passageways is controlled withvalves402 and403, respectively, to route the fluid either to thesequestration reservoir301 or the filtered inlet of thevenous reservoir106, at the user's option.
• The[0139]cartridge120 in the embodiment illustrated in FIG. 3A comprises anintegral sequestration reservoir301 for receiving fluids removed from a patient through first and secondtubing suction lines170 and172, respectively, as well as through leftventricle tubing line186. In this regard, it can be seen thatintegral passageways182,184 and192 are fluidly interconnected to thesequestration reservoir301.
• The inclusion of[0140]sequestration reservoir301 in the embodiment of FIG. 3A allows for selective, discretionary use of fluids collected therein. For example, such fluids may be processed to wash and separate red blood cells and other desired components for later reinfusion. More particularly, it can be seen thatstopcock valve303 may be provided oncartridge120, in fluid connection withsequestration reservoir301, to provide for the selective flow of accumulated fluids fromsequestration reservoir301 to a transfer bag (not shown) for subsequent autologous blood salvage procedures and return of the desired components to the patient; or for flow directly to an autologous blood salvage system.
• Alternatively, the embodiment illustrated in FIG. 3A allows for the return of fluids collected in[0141]sequestration reservoir301 directly tovenous reservoir106 via the inclusion of a valve assembly401 incartridge interface region20 that interfaces with an added integral passageway305 incartridge120. Valve401 may be selectively opened/closed by a user or maybe automatically opened when the sequestration reservoir is full. When valve401 is open, fluids collected insequestration reservoir301 will flow through the integral passageway305 withincartridge120, and then throughtubing line129 to a filtered inlet port atvenous reservoir106.
• A[0142]vent307 is provided at the top ofsequestration reservoir301 to vent gas that may accumulate in thereservoir301. Additionally, thecartridge interface region20 may be provided with one or more level sensors for monitoring the fluid level withinsequestration reservoir301. In this regard, afirst level sensor320 may be disposed adjacent to the top end ofsequestration reservoir301, wherein upon sensing of fluid at a predetermined level withinreservoir301,control unit10 will operate so as to automatically open valve401 so as to flow fluid fromsequestration reservoir301 tovenous reservoir106. The system may be set up by the user so that, upon sensing fluid at the upper level sensor, thecontrol unit10 may stop the suction and vent pumps and provide an alarm so that the user can empty the sequestration reservoir. Alternatively, instead of stopping thevent pump33, thecontrol unit10 may automaticallyclose valve402 andopen valve403 to re-route the vent pump outlet from the sequestration reservoir to the venous reservoir. Asecond level sensor322 may also be provided and disposed downward from the first sensor, wherein upon the detection of fluid, an alarm/indication may be provided atuser interface50. Alternatively,sequestration reservoir301 may be provided with a continuous level sensor such as that described in connection with FIG.12. Alternatively, the level in thesequestration reservoir301 could be sensed continuously by measuring the pressure at the bottom of the reservoir through the membrane with a pressure sensor.
• [0143]Sequestration reservoir301 includes adefoamer element795 which may be vertically disposed to facilitate in the removal of gas from fluid accumulating invenous reservoir301. Aftercartridge120 is loaded into its mountingassembly21,defoamer push bar790 is advanced to a position where it applies pressure through the vinyl backing ofcartridge120 against the side ofdefoamer795. This pressure ensures that there are no flow paths betweendefoamer795 and the vinyl backing and that any fluid which enterssequestration reservoir301 is caused to flow through the defoamer.
• It should also be noted that, since in many potential applications, the blood collected through left[0144]ventricle tubing line186 may be of a high quality nature, the embodiment illustrated in FIG. 3A comprises further features that allow for the selective, direct flow of such blood from thecartridge120 tovenous reservoir106. In particular, FIG. 3A illustrates the inclusion of integral passageway spurs192aand192b, each of which interface with acorresponding valve assembly402 and403, respectively, provided in thecartridge interface region20. In the event that a user would like blood collected from the left ventricle to be collected insequestration reservoir301, the user may selectively controlvalve403 to be closed andvalve402 to be open whereupon the collected blood will flow through integral passageway spur192aintointegral passageway185 tosequestration reservoir301. Alternatively, a user may selectively causevalve402 to close andvalve403 to open whereupon the collected blood will flow through integral passageway spur192b, adjoiningintegral passageway164, and out ofcartridge120 throughtubing line129 to a filtered inlet port ofvenous reservoir106.
• The component interface region may comprise a[0145]level sensing assembly87 positioned in immediate, predetermined relation to the region in whichvenous reservoir106 is mounted. In this regard, thelevel sensing assembly87 is operable to monitor the level of fluid within thevenous reservoir106 on an ongoing basis during procedures. Such monitored fluid level may be presented both graphically and in volumetric measure terms atuser interface50. Additionally, the fluid level value may be monitored in relation to predetermined minimum and maximum values, wherein automated stowage or stoppage ofpump31 may be effected when the fluid level drops below corresponding predetermined minimum values and wherein an alarm/indicator may be otherwise provided atuser interface50 upon detection of an out-of-range condition.
• One embodiment of such a level sensor is illustrated in function form in FIG. 12. In this embodiment,[0146]level sensor87 operates on the theory of time domain reflectometry which uses pulses of electromagnetic energy to measure distances or fluid levels. Thelevel sensor87 generates aninitial pulse97a. When the initial pulse reaches the surface of the blood inreservoir106, part of the pulse is reflected. The level in the reservoir is determined by the measured differential of the reflectedpulse97cand the transmitted pulse97bin a manner known to those of skill in the art.Level sensor87 is mounted internally to thecontrol unit10 in a location adjacent to thevenous reservoir106. Thelevel sensor87 is oriented such that the level sensor is approximately parallel to the vertical wall of the venous reservoir and extends from the lower most portion to the upper most portion of the venous reservoir. In between thelevel sensor87 and thevenous reservoir106 is a thin wall, covering or coating that is thin enough and made of a material (e.g. plastic) permitting the transmission of signals into the venous reservoir from the sensor as well as receiving reflected signals from the venous reservoir, in particular reflections from the fluid level in the venous reservoir. The thin wall, covering, or coating would allow positioning the level sensor as close as possible to the external wall of the venous reservoir to aid in signal transmission and reception. The wall could be a part ofcontrol unit10. The level sensor is positioned approximately in a vertical plane such that the transmitting and receiving portions of the sensor would cover the entire height of the venous reservoir to ensure the venous reservoir level could be sensed from a full to empty condition. While a vertical orientation is described, an angled orientation would also functionally work and may add resolution to the level signal.
• As previously noted,[0147]user interface50 includes amain display54,user control knob52 andbackup display55. Themain display54 andbackup display55 may be provided to display monitored parameters regarding one or more of the fluid circuits discussed hereinabove, to provide alarm indications as noted hereinabove, and to establish predetermined minimum/maximum or control values for monitoring and control purposes. Of particular note, thebackup display55 is located immediately adjacent to controlknob52, wherein when a given parameter is being established viacontrol knob52, a user may readily observe thebackup display55 as theknob52 is being manipulated.
• Another embodiment of the[0148]disposable assembly100 and component interface ofcontrol unit10 are schematically illustrated in FIG. 3B. As can be seen, the embodiment illustrated in FIG. 3B is similar in many respects to the embodiment illustrated in FIG. 3A. As such, components having common functionality between the two embodiments are labeled with the same reference number and the corresponding description of such components set forth above is applicable. Features unique to the embodiment illustrated in FIG. 3B are described below.
• As shown in FIG. 3B,[0149]tubing line116 includes afirst spur116ainterconnected to an upstream side of anarterial filter118, and a second tubing spur116binterconnected to a downstream side ofarterial filter118. Second tubing spur116bmay be utilized for replacement/bypass ofarterial filter118, while the first tubing spur116ais utilized during oxygenated blood return to a patient during cardiopulmonary bypass procedures. In particular, valve assembly90 is provided to receive tubing spur116a, and valve assembly91 is provided to receive tubing spur116b, wherein valve assemblies90,91 may be selectively and/or automatically opened/closed together with other valve assemblies, to establish the desired fluid flow (e.g., through tubing spurs116bduring filter replacement, and through tubing spur116aduring bypass procedures).
• Valve assembly[0150]93 is provided to receivetubing line125 and may be selectively and automatically opened/closed, including, for example, selectively opened for retrograde cerebral perfusion or to quickly reprime thevenous tubing line104 after initial bypass procedure ends in the event the patient needs to go back on bypass.
• During bypass[0151]procedure control unit10 may operate to closetubing line122 and direct blood flow fromarterial filter118 throughpurge line119 when bubbles are detected bysensor114. Further, in the embodiment of FIG. 3B,control unit10 may operate to closetubing line122 by closingarterial line valve92 when gaseous bubbles are detected bysensor114 and/orsensor126 thereby causing blood to flow back to thereservoir106 viatubing line125. For such purposes,tubing line125 is interconnected to thevenous entry module108 of the venous circuit as described hereinabove. During cardioplegia delivery (e.g., whenpump35 is operating andvalve96 is open) and/or during hemoconcentration procedures (e.g., when pumps37 and38 are operating to circulate blood through a tubing hemoconcentration assembly134), the monitored pressure may be compared with a corresponding predetermined minimum value to insure an adequate fluid pressure at cartridge120 (e.g., so as to reduce any risk of cavitation or air transfer across the membrane of oxygenator112). In the event the monitored pressure is below the desired level, automated stoppage of pump35 (e.g., in the case of cardioplegia delivery) and automated stoppage ofpumps37 and38 and closure of valve96 (e.g., in the case of hemoconcentration procedures) may be effected and an alarm/indication may be provided atinterface50.
• [0152]Integral passageway130 is fluidly interconnected to atubing loop132, and may also be fluidly interconnected to a tubing/hemoconcentrator assembly134. In the later regard, tubing/hemoconcentrator assembly134 may be optionally interconnected to thedisposable assembly100 when use of a hemoconcentrator134aand waste bag134bis desired.
• Pressure sensor[0153]86 may also be provided to sense the pressure within the tubing/hemoconcentrator assembly134 in the event that a hemoconcentrator is employed. In this regard, the monitored pressure may be compared with a predetermined minimum pressure value necessary to insure flow through the membrane of hemoconcentrator134a, wherein if the pressure falls below the minimum an alarm or other indication may be provided atuser interface50. Further, the monitored pressure inassembly134 may be compared with a predetermined maximum pressure value. A monitored pressure that exceeds the maximum value may indicate that the outlet of hemoconcentrator134ahas become occluded, wherein automated stoppage ofpump37 and pump38 may be effected and an alarm or other indication may be provided atuser interface50.
• In the embodiment of FIG. 3B the downstream end of[0154]tubing loop140 is interconnected withintegral passageway142 having afilter144 interposed therewithin.Filter144 serves to filter particulates greater than a predetermined size (e.g., greater than 0.2 microns via a filter screen).Filter144 may also comprise at least one vent (not shown) having a hydrophobic membrane for venting air bubbles. In this regard,filter144 may include two hydrophobic vents (not shown), one on each side of a vertical filter screen, for venting air bubbles from a priming solution during priming and for venting air bubbles from solutions passing therethrough (e.g., cardioplegic crystalloid solution during cardioplegia delivery).
• Pressure sensor[0155]16 is provided incartridge interface region20 for sensing the fluid pressure withinintegral passageway142. The monitored pressure may be compared with a predetermined value during cardioplegia delivery (e.g., whenpump36 is operating andvalve96 and one of thevalves99 are open). If the monitored pressure exceeds the predetermined value (e.g., indicating thefilter144 is clogged), then an alarm/indication can be provided atinterface50, and thefilter144 may be automatically or manually bypassed (e.g., via operation of valve93 so as to open bypass line143).
• For purposes of priming and for filtering in conjunction with priming,[0156]valve assemblies94 and95, respectively, are provided to receivetubing lines119 and166, respectively, for selective and automatic closure/opening.
• With further regard to the delivery of the crystalloid solution, valve assembly[0157]93 is provided to receive crystalloid bypass tubing line143 for selective and automatic opening/closure thereof, including for example opening upon clogging ofcrystalloid filter144, as detected by pressure sensor16. That is, in the event sensor16 detects a pressure greater than a predetermined value, valve assembly93 can be automatically and/or selectively opened wherein crystalloid solution will flow through bypass tubing line143 and back intointegral passageway146.
• The downstream ends of[0158]tubing loops178 and180 are interconnected tointegral passageways182 and184 ofcartridge120, which passageways182,184 are in turn each fluidly interconnected with theintegral passageway164 for the passage of suctioned blood out ofcartridge120 and throughtubing line129 to the filtered inlet ofvenous reservoir106 for reuse.
• Further,[0159]passageway164 may be interconnected to an outlet (not shown) that may be selectively utilized for passing suctioned blood into a separate reservoir (not shown).
• Finally,[0160]disposable assembly100 may also include a transfer bag/tubing assembly194 (not shown in FIGS. 2A and 2B) that may be utilized for receiving blood frompassageway130 ofcartridge120. The transfer bag/tubing assembly194 may be employed, for example, to remove excess fluid from the circuit during bypass procedures, to retrieve blood from the circuit post bypass for later reinfusion to the patient or for cell-saving procedures.
• [0161]Pressure sensor14 may also be used as a means of checking for proper arterial cannula placement before going on bypass. When arterialpatient valve92 is open during test connection mode as described hereafter, the patient pressure at the cannula can be read atsensor14.
• While FIGS. 3A and 3B correspond with embodiments implementing various aspects of the present invention, other potential embodiments which incorporate one or more of the inventive features of the present invention would be apparent to those skilled in the art.[0162]
• V. Disposable Cartridge[0163]
• As illustrated in FIGS.[0164]13-24, theperfusion cartridge120 can be made of a variety of materials including polymeric materials, metals and composite materials. In a preferred embodiment, theperfusion cartridge120 of the present invention is formed from polymeric materials which are thermoformed medical grade plastics.Cartridge120 has a plurality of fluid passageways integrally defined therewithin. By way of example,cartridge120 may be constructed from a clear, molded front piece (e.g., molded plastic which defines all but a back side of each integral passageway), and an interconnected, pliable back layer (e.g., a vinyl sheet that defines a back side of each integral passageway) attached thereto. In addition to the integral passageways,cartridge120 may include one or more passive components. Such components may include one or more filters and bubble traps. Various conduits may be formed into theperfusion cartridge120 during manufacturing such that each of the top and bottom plates or pieces partially define portions of the conduits. Typically, thefront portion802 is translucent to allow for visual inspection of each of the conduits that flow through thecartridge120. In addition, the integrated fluid conduits are located at various depths and can pass above or below each other.
• FIGS.[0165]13-24 are various views ofcartridge120. FIG. 13 is a front perspective view. FIG. 14 is a front plan view. FIGS. 15 and 16 are right and left side views, respectively. FIGS. 17 and 18 are top and bottom views, respectively. FIG. 19A is a back plan view and FIG. 19B is a back perspective view. FIG. 20A is a cross-sectional view along line A-A of FIG. 19A. FIG. 20B is a detail view of a portion of FIG. 20A. FIG. 21 is a cross-sectional view taken along lines B-B of FIG. 19A. FIG. 22 is a back plan view with the flexible back layer removed to better show the various fluid channels and related components withincartridge120. FIGS. 23A, 23B,24A, and24B are partial views of a valve station located incartridge120.
• In each of these figures, components that have been previously described retain the same reference numerals. This includes the various internal passageways or fluid conduits formed by the cartridge. The various inlet and outlet ports of the cartridge have been labeled with the reference numeral of the external tubing line connected at the port. Those portions of the cartridge which interface with pressure or temperature sensors or with valves comprise sensor or valve stations and are labeled individually with the reference numeral of the sensor or valve with which they interface followed by a small “a”. Thus, for example, the sensor station interfacing with cardioplegia[0166]line pressure sensor18 is referenced as18a. Features ofcartridge120 not previously described are discussed below.
• [0167]Cartridge120 includes a front substantiallyrigid portion802.Front portion802 defines substantially all of the structure of the various components and passageways of the cartridge. For example,front portion802 defines the shape and contour ofsequestration reservoir301 except for the back portion thereof. Aflexible back layer804 is connected to the back side offront portion802. Any flexible, durable, fluid impermeable material which is suitable for contact with a patient's blood may be used. A suitable material is a sheet of vinyl. The sheet can be attached to the front portion by use of medical adhesives or welding techniques known to those of skill in the art. The back layer may be comprised of a flat sheet or, alternatively, can be formed into a contoured shape. Formed elements in the vinyl can assume various formed shapes and can include pressure diaphragms as shown in FIGS. 19A and 19B, valve diaphragms as shown in FIGS. 23A, 24A,23B, and24B, fluid passageways matching those on the cartridge as shown in FIGS. 19B and 20B,sequestration reservoir301 andsequestration reservoir defoamer790 as shown in FIGS.15 to21. The pressure diaphragms isolate the pressure sensor from the cartridge to provide more accurate pressure readings. The valve diaphragms help lower the resistance to valve opening and closing, and can provide a transition zone in the fluid flowing from the passageway through the valve. Fluid passageways can be shaped to smooth fluid flow and/or provide a more consistent cross sectional fluid volume through passageways particularly where entering or exiting other features such as ports, pressure sensing regions or valve regions. The sequestration reservoir volume may be increased and/or flow enhanced through vinyl forming. In particular, by forming a pocket in the vinyl, the defoamer may be placed into the pocket as best seen in FIG. 20A. A pocket also helps form a sealing interface when positioned againstdefoamer push bar790 located in thecartridge interface region20. Vinyl forming may be accomplished by forming techniques known to those skilled in the art.
• As seen in FIGS. 20A and 21, the sequestration reservoir includes a[0168]defoamer support element806.Support element806 comprises a plurality of struts806aand806bwhich are spaced apart on either side ofdefoamer790 and which support defoamer790 in thesequestration reservoir301.
• As shown in FIGS. 23A, 23B,[0169]24A, and24B, the valve stations include avalve chamber808 in thecartridge120. Thevalve chamber808 includes at least first810 and second812 passageways. Aflexible member804 is positioned over thevalve chamber808 above first810 and second812 passageways.
• Typically,[0170]first passageway810 contains a raisedlip portion816 which extends towardflexible back layer804. A portion ofbacklayer804 adjacent raisedlip portion816 is formed as a flexible pleated member814. Aplunger818 provided in the structural interface is located over thevalve chamber808. To close the valve,plunger818 is caused to impact and deflect the flexible member814 to contact the raisedlip portion816 of thefirst passageway810. This deflection and contact prevents fluid from flowing out of or into thefirst conduit810. To open the valve, theplunger818 is retracted from the raisedlip portion816 such that fluid pressure displaces the flexible member814 from the raisedlip portion816 of thefluid conduit810.
• In a further embodiment of the present invention, the[0171]cartridge120 includes a first integral passageway path which occurs in a first plane. The first integral passageway has an entry port and an exit port from thecartridge120. The first integral passageway, thus, defines first and second areas incartridge120, both lying in the first plane and being separated by the first integral passageway.Cartridge120 also includes a second integral passageway which has an entry port and an exit port from the cartridge. The entry port of the second integral passageway occurs in the first area of the first plane, and the exit port of the second integral passageway occurs in the second area of the first plane. Thus, the first and second conduit paths crossover at a point. At the point of cross-over of the first and second integral passageways, the second integral passageway occurs in a second plane.
• In the present invention, as shown in FIGS.[0172]13-24, theperfusion cartridge120 can be interconnected with a number of fluid circuits. The fluid circuits include a cardiopulmonary circuit which include the venous and arterial circuits, a cardioplegia circuit, a cardiotomy or suction/vent circuit and a fluid management or priming circuit all as previously discussed. The cardiopulmonary circuit is designed to functionally replace and/or supplement the heart and lungs during heart surgery. The cardioplegia circuit delivers cardioplegia to the heart to discontinue beating in a manner that will facilitate operative procedures and minimize damage to the myocardium. The cardiotomy circuit is used to withdraw or suction blood and other fluids from the open heart or chest cavity and deliver it to the cardiopulmonary circuit. The fluid management circuit is used to provide priming fluid, i.e., blood, to thedisposable assembly100 and maintain a proper flow of fluid in the other circuits. In another embodiment, two cartridge assemblies may be interconnected. For example, a first cartridge assembly including the cardioplegia circuit may be connected to a second cartridge assembly including a cardiopulmonary circuit, a cardiotomy circuit and a fluid management circuit can be interconnected.
• In the embodiment described herein the cardiopulmonary (arterial and venous) circuit is not interconnected with the[0173]disposable cartridge120 except for air purge and fluid sampling functions. However, it should be appreciated that the cardiopulmonary (arterial and venous) circuit could be included within thecartridge120.
• VI. System Architecture.[0174]
• [0175]Control unit10 includes a plurality of processors which together withsystem user interface50, pump user interfaces31b-36band pumpcontrol knobs31a-36aoperate to control various components of thecontrol unit10 according to preprogrammed and/or user established instruction sets and user input. In this regard, and referring now to the block diagram of FIG. 25, acontrol unit10 comprisingprocessors300,306,304 and312 is illustrated.Processor300 is provided to interface with themain display54 of theuser interface50, and may be a personal computer provided with graphics to facilitate operation of themain display54. Monitor/control processors306 are separately provided for automated monitoring and control, respectively, of the various components comprisingcontrol unit10.Backup display55 may also be provided with redundant monitoring/control processors304, separate fromprocessors300 and306. It is also noted that valves, sensors, flow control components, temperature control components, gas circuit components or other components comprisingcomponent interface region12 may also be separately provided with separate monitoring and control processing chips. Each pump31-36 also has its own monitor/control processor pairs312. All of the above-mentioned processors are interconnected through a communications network.
• [0176]Processors300,306,304, and312 are interconnected to receive monitoring signals from the various pressure, bubble, temperature, oxygen saturation, hematocrit, level, flow, andother sensors314 that comprise thecontrol unit10, and that interface with thedisposable assembly100. In this regard, the monitored signals provide an indication of measured values which may be processed at one or more of the processors in relation to one or more predetermined maximum/minimum values so that one or more of the processors may issue control signals to flow control components380,temperature control systems330 orgas circuit components340 based on preprogrammed instruction sets and/or other indication signals tosystem user interface50 and/or pump user interface31b-36bto prompt a user regarding a monitored condition of potential concern. As will be described,system user interface50 allows a user to input or modify one or more of the processors parameter settings which one or more of the processors rely upon in issuing instruction signals to flow control components380,temperature control systems330 and/orgas circuit components340 and indication/alarm signals tosystem user interface50.
• As indicated in FIG. 25, the flow components[0177]380 comprising thecontrol unit10 include the various pumps and valve assemblies described hereinabove, as well as thevenous line clamp46. Based on signals received from the various pumps or pressure sensors, the processors may be preprogrammed to automatically calculate flow rates in the various fluid circuit lines for monitoring and display atuser interface50. Thetemperature control systems330 include controls for establishing the temperature and flow of heating/cooling fluid through thecardioplegia heat exchanger148 and for controlling the temperature and flow of the heating/cooling fluid circulated through a heat exchanger interconnected to or integrally provided withoxygenator112. Other features and functions of the system architecture are described in other sections herein.
• 1. Gas Circuit[0178]
• Referring now to FIG. 26, a schematic block diagram for the[0179]gas circuit340 referenced in FIG. 25 will be briefly described. Thegas circuit340 may comprise a plurality of external gas sources for air (342a), for O₂(342b) and for an O₂/CO₂mixture (342c), having corresponding in-line filters344a,344band344c, andpressure regulators346a,346b, and346c, for flowing the respective gases viacorresponding check valves348a,348b, and348cinto avalve manifold350.Valve manifold350 includesvalves352a,352band352cset to establish the desired flow/relative percentage of each gas type. Flow meters354band354cmay be provided upstream (as shown) or downstream ofvalve manifold350 for the O₂/CO₂source line and O₂source line and/or air source line. As illustrated, the three gas source lines may flow into a common line downstream of themanifold350. The common line then passes through atotal flow meter356. Fromflow meter356 the single stream may be passed through avaporizer358 outside ofcontrol unit10 for introduction of an anesthetic agent. Apressure sensor360 may be provided to monitor the fluid pressure atfilter362. In the event the pressure exceeds a predetermined maximum value (e.g., indicating thatfilter362 is clogged), an alarm or other indicator may be provided atuser interface50. Additionally, to insure the desired pressure atoxygenator112, anadditional pressure sensor364 may be utilized downstream of thefilter362 and upstream of theoxygenator112. In the event the pressure exceeds a predetermined maximum value,valves352a,352b, and352cmay be closed partially or fully to prevent gas bubbles from crossing the oxygenator membrane into the blood. The gas fromfilter362 then flows into theoxygenator112 viainlet port518aprovided in thecontrol unit10 through theoxygenator112, and into thecontrol unit10 via theoutlet port518b(on FIG. 8B). At that point, the gas flow stream will comprise the oxygen-depleted, CO₂-containing exhaust fromoxygenator112. Such exhaust may then be passed through aliquid leak detector366 for monitoring purposes (e.g., to detect any leakage through the oxygenator membrane of blood or priming fluid), and into a scavenge line. An optional gas concentration monitoring system may be included having sampling pumps368aand368bto draw gas samples downstream and upstream, respectively, ofoxygenator112. The gas samples may be passed through a dryer369, analyzed bymonitor370, and returned to the scavenge line. Theflow meters354b,354c,356, and monitor370 may be interconnected touser interface50 to provide information for display and monitoring for alarm indications. The information provided by the flow meters and concentration sensors, combined with the known blood flow rate, venous saturation, hematocrit and temperature, can be used to estimate arterial blood gas concentrations (e.g., pO₂and PCO₂). The gas concentrations measured by themonitor370 can be compared to the concentrations calculated from the flow rates measured byflow meters354b,354c, and356. If the difference between measured and calculated concentration exceeds a predetermined maximum value, an alarm/indicator may be provided atuser interface50. The arrangement of flow meters and valves allows a comparison of flow meter measurements to verify correct operation of individual flow meters. For example,valves352cand352acould be closed, allowing flow only from the O₂source throughflow meters354band356. The measured flow rates frommeters354band356 should be equal if the flow meters are operating properly. Similar checks/tests could be performed with respect to verifying gas source composition and connection.
• VII. System User Interface.[0180]
• The[0181]system user interface50 includes acontrol knob52 anduser displays54 and55 that provide for the automatic redundant display of alarm indications and certain monitored parameters, and provide for selective user control of various system components. Bothmain display54 andbackup display55 may provide a functional user interface (e.g., via touch screen capabilities). Important subsets of the various features described below with respect tomain display54 may also be provided atbackup display55, either all the time or if failure ofmain display54 is detected by the system or by the user. In addition to its backup display functions,display55 serves primarily as a numeric data entry screen, as described below.
• Numeric data entry is accomplished by using the[0182]control knob52 and both user displays54 and55, as follows. The user contacts a touch screen button on eitherdisplay54 or55 to initiate modification of a particular numeric value represented by that button. The value being modified then appears (usually in a large font) ondisplay55, as well as appearing within the button originally contacted on display54 (or its analog on54, if the original button was on display55). At this point, theknob52 may be turned to affect changes in the value displayed in both places. This dual display concept is to provide redundant display of important data parameters as are they are being adjusted, thereby giving an important safety cross-check against incorrect data entry. In most cases, as the number is being adjusted on the screens, it is also taking immediate effect in the system (on-line adjustment). For example, turning the knob to adjust venous line clamp position causes the clamp to move immediately to the value entered. Data entry is terminated by pressing theknob52 in, or by touching the original touch button or anywhere else on the touch screen. Because of the on-line nature of such adjustments, terminating the data entry is not in anyway “confirming” or “setting” the value entered; that has already happened. Terminating the data entry simply exits the adjustment mode for that particular value. There are many examples of specific data entry actions throughout this section.
• FIGS.[0183]27-33 illustrate examples of one embodiment of thesystem user interface50, and are presented for illustrative purposes. The arrangement, controls, and information presented on the user interface are not limited to that shown here.
• As shown in FIG. 27, processor-driven[0184]display54 is controlled to define three display regions for information presentation and user control. The screen ofdisplay54 comprises afirst region200, asecond region220, and a third region240. Thefirst region200 provides for automatic alarm status messages and corresponding user control buttons that are presented when monitored system parameters exceed/fall below predetermined established values (e.g., factory set values or user established values). Thesecond region220 and third region240 will be described further hereinbelow.
• Alarms:[0185]
• The[0186]first region200 ofdisplay54 provides alarm and status messages that are presented when certain monitored system parameters exceed/fall below selectable, predetermined established values and/or an otherwise undesired condition is detected. FIGS.28A-28F illustrate a variety of such messages. In this regard, it should be noted that the messages are presented in relation to their relative degree of importance. That is, in the illustrated embodiment, messages which are of predetermined “critical” nature are displayed against a red box background while messages of a predetermined “warning” nature are displayed against a yellow box background. Further, it should be generally noted that when a condition is detected that would trigger a “critical” message such message will be presented together with a touch screen button that may be immediately contacted by a user to override the alarm. That is, detection of a “critical” condition may result in automatic stoppage of a given system component (e.g., pump31 or pumps35 and36), in which case, the “critical” message may be presented with a touch screen button that may be contacted to restart the stopped component. Alternatively, detection of a “critical” condition may result in display of a button (e.g., with the “critical message”) that may be contacted by a user to effect an immediate stoppage of a predetermined component displayed with the message (turn off the override). Additionally, it should be noted that with respect to the “critical” messages, a predetermined hierarchy is preferably established wherein the order of presentation of such “critical” messages will be determined in relation to the hierarchy as preprogrammed at the embedded processor.
• The following are examples of “critical” conditions that may trigger an automatic response and a “critical” alarm message. Many other critical alarms may exist in the system:[0187]
• 1. Detection of an air bubble in[0188]tubing line122 ortubing line156. Such a detected condition may automatically trigger stoppage ofpump31 and/or pumps35 and36. Selective, user response buttons may be provided with the corresponding “critical” messages to provide a user with the touch screen capability to restart the stopped pump.
• 2. Detection of a pressure in[0189]line122 or of a pressure inline156 that exceeds a corresponding predetermined maximum value. Detection of this condition may trigger an automatic stoppage ofpump31 and/or pumps35 and36. Alternatively, the pump may slow until the desired range is re-achieved. Again, button displays may be provided for selective, user restart of the affected pumps.
• 3. Detection of a volume level in[0190]venous reservoir106 that exceeds or falls below a predetermined level.
• Various detected conditions are reflected by FIGS.[0191]28A-28F.
• Referring specifically to FIG. 28A, a “critical” alarm box[0192]202a′ is presented with the message:
• “LOW LEVEL-Pump Stopped”[0193]
• This message indicates that the volume in[0194]reservoir106 has been detected to have fallen below a predetermined alarm value. The message also indicates thatpump31 has been automatically stopped. It should also be noted that the message box202a′ provides a touch screen button entitled “Restart Pump”202a″. Button202a″ allows a user to immediately take responsive action, i.e., to contact the “Restart Pump” button202a″ so as to startarterial pump31, by overriding the alarm.
• At this point, it should also be noted that in the event of a “critical” message (e.g., the message is displayed against a red background), the[0195]control unit10 may provide for a first audible alarm to a user. Further, in the event of a non-critical message (e.g., a “warning” message displayed against a yellow background),control unit10 may provide a second audible alarm that is different than the first. Correspondingly, thefirst region200 ofdisplay54 may be provided with a touch screen “Mute”button204 which allows a user to selectively disable the most recent audible alarm. That is, audible alarms may be successively and separately “muted” in relation to each successive triggering-alarm event. The “Mute”button204 only appears when there is one or more audible alarms currently sounding, and it disappears after being pressed (thereby stopping the audible signal) until the next triggering event occurs causing a new alarm and audible to occur. Thus, the “Mute” button only appears when needed.
• FIG. 28B illustrates an alarm box[0196]202b′ with the message:
• “LOW LEVEL-Pump On”.[0197]
• This message indicates that the volume in[0198]reservoir106 has been detected to have fallen below a predetermined value and that pump31 is on (because the alarm is overridden). Block202b′ also provides a touch screen button entitled “Stop Pump”202b″ to allow a user to immediately stoparterial pump31 upon contact with button202b″.
• In FIG. 28C an[0199]alarm box202c′ is presented with the message:
• “LEVEL OK-Pump Stop Disabled”.[0200]
• This message indicates that the volume in[0201]reservoir106 is within an acceptable range but that the automatic pump stoppage feature ofcontrol unit10 has been overridden (e.g., the user has contacted the button202a″ shown in FIG. 28A). To reactivate the automated pump control feature (turn off the override), a user may contactbutton202c″.
• FIG. 28D illustrates a plurality of “critical” alarm boxes corresponding to[0202]response buttons203a″,203b″, and203c″ each of which would be illustrated against a red background, and a single “warning”alarm box206a′ which would be presented against a yellow background. FIG. 28E illustrates a plurality of “critical” alarm boxes and a plurality “warning” alarm boxes. The presence of the “MORE button208aindicates that there are more alarms than can be displayed withinregion200, which can be selectively cascaded into thesecond display region220 via contact with the “MORE”button208a, as shown in FIG. 28F. Pressing the “LESS”button208bin FIG. 28F will collapse the alarms back withinregion200, as shown in FIG. 28E.
• Dedicated Area:[0203]
• The[0204]second region220 presents selected, predetermined important information sets to monitor bypass parameters, including values corresponding with selected fluid flow parameters monitored by various components ofcontrol unit10, as well as other parameters monitored by external systems. More particularly, in the screen display embodiment illustrated in FIG. 29, five different information sets are presented in fivecorresponding sub-regions222,224,226,228 and230, having the sub-region headings of “Venous”, “Arterial”, “Cardioplegia”, “Blender” and “Other”, respectively. The alphanumeric information in the different sub-regions may be color coded for ready observation (e.g., the alphanumeric information may be blue in “Venous”sub-region222, red in “Arterial”sub-region224, yellow in “Cardioplegia”sub-region226 and white in “Blender” and “Other” sub-regions228 and230, respectively).
• The information displayed in[0205]sub-region222 under the “Venous” heading pertains to parameters of the venous blood flowing from a patient intovenous reservoir106 ofdisposable assembly100 during a bypass procedure. More particularly, the monitored venous blood values include a measure of the venous blood oxygen saturation (i.e., “SAT”), venous blood hematocrit (i.e., “HCT”) and venous blood temperature (i.e., “Temp”). Such values are monitored by corresponding oxygen saturation hematocrit andtemperature sensors85 and81, respectively, in thecomponent interface region12. Of note, information regarding the volumetric content ofvenous reservoir106 is provided both in an animated manner and numerically by the graphic reservoir insub-region222. That is, as the level of fluid raises and lowers invenous reservoir106 during a bypass procedure, a corresponding animated fluid level (e.g., illustrated in red) will be presented in the graphic venous reservoir shown insub-region222. Additionally, a numeric representation of the volumetric level withinvenous reservoir106 will be increased/decreased. The volumetric level of fluid withinreservoir106 is determined via thelevel sensor87 located incomponent interface region12.
• The “Venous”[0206]sub-region222 further includesobject buttons222a,222band222chaving touch screen capabilities to allow a user to selectively controlvenous line clamp46 of thecomponent interface region12 oncontrol unit10. In particular, the “Full Open” and “Full Close”buttons222aand222c, respectively, allow a user to selectively, fully open and fully closevenous line clamp46 upon screen contact. Object button222ballows a user to select a desired percent of fluid passage throughvenous tubing line104 atvenous line clamp46. That is, pursuant to contact with button222b, a user may then utilize thecontrol knob52 onsystem user interface50 to set a desired percentage for fluid passage throughtubing line104 atvenous line clamp46. The desired percentage is established by dialing/rotatingknob52 until the desired value is displayed bymain display54 and back updisplay55. The VLC is moved immediately to the desired position as the knob is moved. A user may then either push theknob52 or contact button222bor any other touch screen portion ofdisplay54 to exit the adjustment mode. For example, ifvenous line clamp46 is in an open position and a user desires to reduce the flow of venous blood flow into venous reservoir106 (e.g., due to a detected high level of fluid within venous reservoir106), a user could contact button222band “close” venous line clamp46adesired amount via rotation ofcontrol knob52. The set flow percentage will be presented in an illuminated manner within the center of object button222band on the back updisplay55. The percentage is displayed as a percent of flow expected if the venous line clamp was fully (100%) open.
• The information presented within[0207]sub-region224 under the heading “Arterial” pertains to ongoing monitored parameters of the blood passing fromvenous reservoir106 throughoxygenator112 for return to a patient. More particularly, the monitored parameters include the pressure of the oxygenated blood in line122 (i.e., “Pressure”), the flow rate of the blood at pump31 (i.e., “Flow”) and the temperature of the blood in line122 (i.e., “Temp.”). The pressure and temperature values are monitored on an ongoing basis by thepressure sensor14 andtemperature sensor88 provided incomponent interface region12 ofcontrol unit10. The flow rate may be automatically determined by monitoring the RPMs ofarterial pump31 at the pump processor312 and by using the monitored RPM values with stored stroke volume-values corresponding withpump31 to calculate flow rate, or to display the flow rate from a flow meter. Such flow rate may be automatically adjusted to compensate for any blood flow downstream ofpump31 that is not directed througharterial tubing line122. Arterial blood flow may be adjusted to compensate for the flow diverted to the cardioplegia circuit (or other circuits). This is done by monitoring the flow throughcardioplegia blood pump35, and adding that much flow toarterial pump31 so that the flow to the patient remains the same. Assuming a flow meter is not available, the flow displayed insub-region224 will be this calculated patient line flow.
• The information set provided under the “Cardioplegia” heading within[0208]sub-region226 includes information corresponding with monitored and preset values corresponding with the cardioplegia mixture flowed throughcardioplegia tubing line156 to a patient. Such parameters include the pressure of the cardioplegia mixture (i.e., “Pressure”), the flow rate of the cardioplegia mixture (i.e., “Flow”) and the temperature of the cardioplegia mixture (i.e., “Temp.”). Such information is obtained via monitoring signals received frompressure sensor18, pumps35 and36 andtemperature sensor153. Again, the signals frompumps35 and36 reflect RPMs which can be employed with stroke volume-related values forpumps35 and36 to determine cardioplegia flow rate, or the flow rate from a flow meter may be displayed.Sub-region226 also provides for the display of information relating to a patient's coronary sinus pressure (i.e., “Coronary Sinus”). Such pressure may be obtained from an auxiliary sensor connected tounit10 or from a conventional operating room patient monitor interconnected tounit10. Additionally,sub-region226 displays values showing a target amount of cardioplegia mixture to be delivered in a given increment (i.e., “Bolus”), the total amount of cardioplegia delivered throughout the case (i.e., “Total”), and the amount of time that has passed between cardioplegia delivery periods (i.e., “Ischemic Time”). The “Ischemic Time” is automatically determined by timing the interval between whenpump35 or36, or bothpumps35 and36, stop and subsequently restart.
• In the sub-region[0209]228 corresponding with the “Blender” heading, monitored and preset values are presented which pertain to the flow of gas to theoxygenator112. In particular, in the gas circuit of FIG. 26, the flow rate of the gas supplied to theoxygenator112 is monitored byflow meter356. Such amount may be displayed in sub-region228 (i.e., “Flow”). Further, the desired, preset oxygen percentage for the inspired oxygen supplied tooxygenator112 is displayed (i.e., “FiO₂”), and the desired preset CO₂percentage of the inspired carbon dioxide supplied tooxygenator112 is displayed (i.e., “FiCO₂”). Such percentages may be displayed via signals provided to one or more of the processors ofunit10 from valves352a-352cin the gas circuit shown in FIG. 26.
• The “Other” sub-region[0210]230 is provided to display other monitored values and is re-configurable by a user. In FIG. 29, the “Other” sub-region has been configured to display values corresponding with a patient's arterial blood pressure (i.e., “Patient Arterial”) and temperature (“Patient Temp.”). Such values may be monitored via an external system (e.g., an operating room monitor) which is interconnected to the embedded processor incontrol unit10. Further, the monitored percentage of CO₂in the expired oxygen passing out ofoxygenator112 may be displayed (i.e., “FeCO₂”). Such percentage may be provided bymonitor320 in the gas circuit shown in FIG. 26.
• Tabbed Area:[0211]
• The third region[0212]240 ofdisplay54 provides for the selective display of various context-driven, information sets and corresponding context-driven user-control options. During a bypass procedure, such information sets and control options may be navigated via selective contact with a plurality of context-driven touch screen tabs, as will be further described.
• Referring to FIG. 30A, when initiating a procedure, a[0213]first tab242 will present a title that changes in corresponding relation to predetermined, pre-bypass steps to be completed. When these steps are completed as described below, thefirst tab242 will present the title “Main” until bypass and post-bypass are complete, when it will present the title “Unload”. In addition totab242, a plurality of other tabs may be selectively employed to access different screen sets. As will be further described,tabs244,246,248,250,252, and254 are available for selection and use at any time during setup or during bypass procedures and will illuminate upon selection.
• “A-V”:[0214]Tab244 may be employed to display a pictorial and/or alphanumeric representation of and selectively controlcertain control unit10 functions relating to the venous and arterial circuits, collectively, arterial-venous circuit. Additionally, touch key buttons are displayed for immediate user control of selected other functions.
• “CPG”:[0215]Tab246 may be employed to a display pictorial and/or alphanumeric representation of and selectively controlcertain control unit10 functions relating to the cardioplegia circuit, e.g., including settings such as cardioplegia ratios or bolus values. Additionally, touch key buttons are displayed for immediate user control of selected other functions.
• “Suction/Fluids”:[0216]Tab248 may be employed to display pictorial and/or alphanumeric representations of and selectively controlcertain control unit10 functions relating to the suction and left ventricular circuits. Additionally, touch key areas are displayed for immediate user control of selected other functions, including the addition of fluids through the prime lines.
• “Gases”:[0217]Tab250 may be employed to display pictorial and/or alphanumeric representations of and selectively controlcertain control unit10 functions relating to the gas circuit. By way of example,tab250 may be employed to establish the gas sweep rate and/or defined FiO₂flow foroxygenator112. Additionally, gas combination ratios, relative concentration values and mass flow rate relative to fluid flow rate may be established forgas circuit340. For example, the user may establish a desired mixture of O₂/CO₂, and air to be established atvalves352c,352b, and352a. Additionally,tab250 may be employed to present various monitored gas pressure readings, including readings taken bypressure sensors360 and364 comprisinggas circuit340.
• “Waveforms”:[0218]Tab252 may be employed to display graphical waveforms and trend settings, and alphanumeric representations, including waveforms corresponding with patient pressure, temperature and ECG signals received by the embedded processor from external or internal systems.
• “Settings”:[0219]Tab254 may be employed to display a pictorial and/or alphanumeric representation of and selectively controlcertain control unit10 functions relating to the various system parameter settings. Additionally, touch key buttons are displayed for immediate user control of other parameter settings.
• Main Tab:[0220]Tab242 in region240 is used to guide the operator through a sequence of steps to setup, load, and prime the tubing set, run the bypass procedure, run post-bypass steps, and, finally, unload the tubing set. In this regard, the title oftab242 changes to “User Setup”, “Load”, “Auto-Prime”, “Main”, and “Unload” as the major steps of the procedure are executed, and where “Main” covers both bypass and post-bypass operations.
• Many of the operations encompassed by the Main tab are sequential in nature, meaning that one step must be completed before the next step(s) can be accomplished. Therefore, the screens in[0221]tab242 enforce this sequential nature by both the instructions presented in message block245, and by not “enabling” touch screen buttons corresponding to later steps until the required prerequisite steps are completed. A button that is not enabled does nothing when touched, and also has a “dimmed out” look, where the text on the button is in a gray color, rather than bright white as exhibited on buttons that are “enabled”. The figures discussed below will illustrate this concept many times.
• User Setup:[0222]
• As noted above, upon initiating a procedure the[0223]first tab242 will present a sequence of titles corresponding with certain pre-bypass procedures to be completed. As illustrated in FIG. 30A, the first such title to be presented bytab242 is “User Set Up”. While the “User Set-Up” title is presented, the context-drivenportion243 of the third region240 presents information in both graphic and narrative form regarding steps to be completed by a user. In particular, in the embodiment shown in FIG. 30A, there are seven set-up steps presented:
• 1. “Insert oxygenator and venous reservoir in holders.” Together with this narrative a graphic depiction is provided corresponding with[0224]venous reservoir106 and oxygenator112 (with heat exchanger when used) to prompt a user to mount thereservoir106 in mountingbracket602 and to interconnect theoxygenator112 to thebracket500.
• 2. “Snap in pre-bypass filter and venous entry module in holders and place venous line in clamp and close cover.” Together with this narrative a graphic depiction is presented that corresponds with[0225]venous entry module108 andtubing line104 positioned withinvenous line clamp46, thereby prompting a user to complete the tasks.
• 3. “Insert cartridge and arterial filter in holders.” Together with this narrative instruction a graphic depiction is presented corresponding with[0226]cartridge120 to prompt a user to mount thecartridge120 in theloading assembly21 provided incomponent interface region12, and prompting a user to placearterial filter118 inbracket760 ofcomponent interface region12.
• 4. “Connect lines to A) arterial filter, B) venous entry module, and C) venous reservoir ([0227]2).” Together with this narrative a graphic depiction is presented corresponding witharterial filter118,venous entry module108, andvenous reservoir106, prompting the user to connectoxygenator outlet line116 toarterial filter118,venous line104 tovenous entry module108, purge tubing line119btovenous reservoir106, andtubing line129 to filtered input ofvenous reservoir106.
• 5. “Place line in bubble sensor and close cover.” Together with this narrative, a graphic depiction is presented corresponding with[0228]bubble sensor114, prompting the user to placetubing line116 relative tobubble sensor114.
• 6. “Place arterial and cardioplegia table lines in clamps and close covers.” Together with this narrative, a graphic depiction is presented corresponding with[0229]arterial valve block196 andcardioplegia valve block195, prompting the user to place arterialpatient line122 relative toarterial valve block196, and cardioplegia topatient line156 relative tocardioplegia valve block195.
• 7. “Install pump loops and close all lids. Hang table pack on console.” Together with this narrative, a graphic depiction is presented that corresponds with a tubing loop (e.g.,[0230]110,178,190,180,132 or140) positioned within a pump assembly (e.g.,31,32,33,34,35 or36), so as to prompt a user to complete all tubing loop/pump installations.
• As will be appreciated, the graphic depictions not only prompt a user to complete a given step, but additionally facilitate disposable component recognition and a ready review of the necessary step.[0231]
• Touch screen buttons found in the lower right corner of the “Main” tab screens being defined here are known as “navigational” buttons, in that they are used to navigate from one “Main” tab screen to the next, or back again. In this regard, it should be noted that the[0232]context portion243 of the “User Set-Up”tab242 comprises amessage block245 comprising the directive: “Follow instructions and then press “Load” to go to Load screen.” Correspondingly, a navigationaltouch screen button256aentitled “Load” is provided that can be contacted by the user so as to proceed from “User Set-Up” procedure step, to an “Auto-Load” procedure step. The “Unload” navigational button may be used to return the Unload screen shown in FIGS. 30K and 30L.
• Load:[0233]
• When the “Load”[0234]button256ais pushed by user, thefirst tab242 will present an “Auto-Load” title with the corresponding procedure-related information presented incontext portion243, as illustrated in FIG. 30B. In thecontext portion243 of the “Auto-Load” tab screen steps are contemplated, (where only the first button260b′ is enabled initially):
• 1. “Load Cartridge and oxygenator”. Of note, this step is presented in the form of a graphic button[0235]260b′ having touch screen capabilities, wherein a user may simply contact the button260b′ so as to causecartridge120 to be automatically retracted or loadingassembly21 to be automatically advanced into operative relation with thecartridge interface region20, and to causeoxygenator112 to be automatically retracted ormoveable carriage member511 to be automatically advanced into operative relation with thestationary face plate510. In this regard, the message block245 comprises the directive “Press ‘Load cartridge and oxygenator’ to automatically load cartridge and oxygenator into system.” While loading is progressing, message block245 may automatically display a series of messages indicating the automatic configuration steps being completed by control unit10 (e.g., opening of valves, zeroing pressure sensors, calibrating VLC46).Block245 may also include a graphic, percent-of-completion or time-to-completion bar (called a progress bar—see FIG. 30F for an example of one) that automatically fills an outlined region in corresponding relation to the degree of completion of task (e.g., as determined by a comparison of elapsed time to a predetermined or predicted time for completion). When this step is completed, a graphic check-mark will be presented within the “Load Cartridge” button260b′ and the “Pressure sensor zeroed, VLC set” box, so as to indicate to the user that these steps have been successfully completed, and the “Load pump loops” button260b″ is enabled, as shown in FIG. 30C.
• 2. “Pressure sensor zeroed, VLC set”. This narrative, presented with a check mark, indicates that the steps described have been successfully completed automatically upon completion of the cartridge/oxygenator load process.[0236]
• 3. “Check pump loops, close all lids”. This narrative corresponds with a tubing loop (e.g.,[0237]110,178,190,180,132 or140) positioned within a pump assembly (e.g.,31,32,33,34,35 or36), so as to prompt a user to check all tubing loop/pump installations.
• 4. “Load Pump Loops”. Of note, this procedural step is presented in the form of a loop touch screen button[0238]260b″. In this regard, upon touching the “Load Pump Loops” button260b″ thevarious tubing loops110,178,190,180,132 and140 will be automatically loaded within thecorresponding pumping assemblies31,32,33,34,35 and36, respectively. In this regard, while automatic loading is being completed, message block245 may include the message “Loading Pump Loops.” or other messages indicating the progress of the pump loading and circuit test procedure. Additionally, message block245 may include a graphic progress bar (as described above and illustrated in FIG. 30F) that automatically fills an outlined region in corresponding relation to the degree of completion of the task. When pump loading is completed, a graphic checkmark will be presented within the Load Pump Loops button260b″, indicating completion of the task, as shown FIG. 30C.
• 5. “Adjust Arterial pump to fully occluded for Prime.” Together with this narrative a pictorial graphic is presented with content that prompts the user to adjust the occlusion setting wheel on the arterial pump rotor to a position that is fully occlusive.[0239]
• As illustrated in FIGS.[0240]30B-30C, thecontext portion243 of the “AutoLoad” screen tab includes a “Set-Up” graphic navigational button258band a “Auto-Prime” graphic navigational button256bhaving touch screen functionality. The “Set-Up” button258bis provided to permit a user to return to the previously described “Set-Up” tab screen shown in FIG. 30A. The “Auto-Prime” button256ballows a user to selectively proceed to the next pre-bypass procedural step, but only after the various loading procedures contemplated by FIGS.30B-30C have been completed.
• Auto-Prime:[0241]
• As shown in FIG. 30D, the “Auto-Prime” tab screen includes a[0242]context portion243 that identifies the following procedural steps:
• 1. “Spike prime and cardioplegia bags.” Together with this narrative a corresponding graphic depiction is presented to prompt/facilitate a user's interconnection of[0243]priming solution bags162, andcrystalloid bags136 to the corresponding tubing lines interconnected withcartridge120.
• 2. “Open water valves.” Pressing this button causes the valves connecting the[0244]temperature control systems330 to the oxygenator and cardioplegia heat exchangers to be opened. After a press, the button changes to “Close water valves” (as shown in FIG. 30E) to allow the user to reverse the process.
• 3. “Check oxygenator and cardioplegia heat exchangers for water leaks.” Together with this narrative a pictorial graphic is presented with content that prompts a user to operate the heater/cooler lines connected to oxygenator[0245]112 (e.g., viaports519a,519bto insure there are no water leaks across the blood side ofoxygenator112 via the heat exchanger thereof, and similarly for the cardioplegia heat exchanger. The user must press the button labeled “Pass” to confirm that there are no leaks, before the “Start priming” button will be valid.
• 4. “Start Priming.” This procedural step is presented in the form of a graphic[0246]touch screen button260c′. Upon pushing thebutton260c′ the various fluid circuits ofdisposable assembly100 will be automatically primed with priming solution frombags162 according to a predetermined protocol.Message block245 may display messages indicating the progress through the automated priming algorithm steps, as seen in FIG. 30F. Additionally, message block245 may include a graphic progress bar that automatically fills an outlined region in relation to the degree of completion of the priming sequence steps, as seen in FIG. 30F. Upon completion of such priming, a completion check-mark will be presented in the middle ofbutton260c′, as seen in FIG. 30G.
• 5. “Check occlusion.” Pressing this button starts the Arterial pump occlusion setting assist algorithm, including progress messages and progress bar in message block[0247]245, as shown in FIG. 30H.
• 6. “Pre-Bypass Filter.” Of note, this step is presented in the form of a[0248]touch screen button260c″ that will be activated and illuminated, or highlighted upon completion ofstep4 noted above. Upon pushing the illuminatedbutton260c″ thecontrol unit10 will automatically initiate pre-bypass filtering of the priming fluid through thepre-bypass filter168 according to a predetermined protocol. Upon completion of such pre-bypass filtering, a completion check-mark will be presented inbutton260c”.
• Upon completion of[0249]step6, the message block245 will read: “Pre-Bypass Filter completed, press ‘Bypass’.” Correspondingly, a user may proceed to bypass operations via pushing a graphic touch screen navigational button256centitled “Bypass”. Alternatively, a user may go back to the prior step of “Auto-Load”, by contacting the graphicnavigational button258cpresented. It should be noted that if a user determines it necessary to proceed immediately to bypass during pre-bypass procedures, the user may contact button256cto interrupt the pre-bypass filtering and initiate bypass.
• On Bypass:[0250]
• Once the “Bypass” button[0251]256cis pressed, thefirst tab242 will present the title “Main” as shown in FIG. 30I. Thereafter, thefirst tab242 will continue to present the “Main” title in a highlighted manner when selected, until the Unload screen is activated.
• As shown in FIG. 30I, “Main”[0252]tab242 selection causescontext portion243 to present narrative instructions inmessage box245 and to present graphic touch screen buttons and other information in three rows entitled “System”, “User Defined” and “Timers”. In particular, thenarrative box245 would normally start with the following instruction:
• “To begin Bypass, turn on the arterial flow”.[0253]
• At this point, the system is ready for bypass operations and the user may proceed to interconnect the patient with the various cannula assemblies that are interconnected with[0254]tubing line104, arterialpatient blood line122,cardioplegia tubing line156 and venttubing line186. Additionally, prior to or at this timesuction tubing lines170 and172 will be readied for use. The patient's venous pressure will initiate the flow of venous blood intotubing line104 wherein the blood is then gravity drained tovenous reservoir106. Alternatively, blood flow may be initiated via the application of vacuum conditions atreservoir106 or the operation of an optional pump interfacing withvenous tubing line104. To initiate arterial, or oxygenated, blood flow to the patient a user would need to manually startarterial pump31 oncontrol unit10 via use of thecontrol knob31a, or a pre-selected automated start bypass procedure as will be further described.
• The user may also select other operations. For example, and as illustrated in FIG. 30I, the “System” row of graphic touch screen buttons provide the following options:[0255]
• “Pre-Bypass Filter.” Of note, this step is presented in the form of a touch screen button[0256]262a. Upon pushing the illuminated button262athecontrol unit10 will automatically initiate pre-bypass filtering of the priming fluid through thepre-bypass filter168, by a predetermined protocol and the flow set by the user using arterialpump speed knob31a.
• “System Recirc.” button[0257]262b: This button provides a user with the ability to cause the recirculation of oxygenated blood within thedisposable assembly100. When the button262bis activated, pump31 will operate withvalve92 closed causing oxygenated blood to recirculate in a closed loop throughtubing line119aand119b(for the FIG. 3A embodiment)reservoir106,oxygenator112 andarterial filter118. Such recirculation will occur when the button262bis graphically presented in a depressed, or activated state, and will continue until the button262bis further contacted, whereupon the button will be presented in an non-depressed, or inactive, state. By way of example, this option may be utilized after set-up procedures, but prior to actual cannula placement.
• “Test Arterial Connection” button[0258]262c: This button provides the user with the ability to effect an automatic test of the interconnection established between the cannula assembly corresponding withtubing line122 and a patient. When button262cis activated, withvalve92 opened and withpump31 off,pressure sensor14 will sense a fluid pressure which should correspond with the patient's blood pressure. As such, the user may compare the sensed pressure value with a predetermined or monitored value or range to determine if the patient interconnection is correct. A user may momentarily operatepump31 at a low rate while monitoring the pressure sensed bysensor14 to further insure proper interconnection.Valve92 must not be left open for an extended period of time because there is a danger of draining the patient through the under-occluded arterial pump. Therefore, button262cshould operate as a press-and-hold (meaningvalve92 only stays open while the user is holding button262cdown) and/or logic must be included to automatically shut the valve after a predefined time (e.g., 3-5 seconds).
• The “System” row of buttons also includes the following buttons:[0259]
• “Patient Info.” button[0260]262d: This button provides the user with the ability to immediately access a screen comprising specific patient vital information (e.g., height, weight, name, patient ID or social security number, lab data, etc.). In this regard, patient information may be input/modified via touch screen functionalities and/or interconnection of a keyboard to controlunit10.
• “Log Event” button[0261]262e: This button provides the user the ability to access a screen for the input/display of specific events which a user may want to keep track of during a procedure (e.g., drug delivery times/amounts). Again, the input of events may be affected with touch screen capabilities and/or a keyboard or other input device interconnected to controlunit10.
• The “User Defined” row of graphic touch screen buttons may comprise any of a number of features that may be pre-selected by a user (e.g., via a “Settings” tab as described below). In the embodiment shown in FIG. 30I the touch screen buttons provide a user with the following control options:[0262]
• “CPG Target” button[0263]264a: This button provides the user with the ability to set the amount of cardioplegia to be dispensed to a patient during any given increment. Upon pushing the button264a, the button will be presented in a depressed, or activated state, whereupon a user may then utilizecontrol knob52 to set the desired amount of cardioplegia bolus to be delivered during the given increment. When the desired amount is displayed in the middle to button264a, the user may again push button264aorcontrol knob52 to exit the adjustment mode.
• “CPG Delivery” button[0264]264b′ with “Reset” button264b″: Button264b′ provides a user with the ability to initiate the delivery of cardioplegia to a patient upon depression of button264b′. When contacted, button264b′ will be graphically presented in a depressed, or activated, state, and will effect the operation ofpump36 or bothpumps35 and36, to achieve the desired cardioplegia mixture (i.e., of crystalloid and blood), as may be pre-selected by a user. Additionally, when button264b′ is activated,valve96 will be opened. Cardioplegia will then flow to a patient throughtubing line156 until the targeted bolus amount set via use of control button264ahas been delivered, whereupon cardioplegia delivery will be automatically stopped. The amount of volume delivered (or yet to be delivered) will be displayed on the control button, and also in the dedicated area. A user may also manually stop cardioplegia delivery at any time by contacting button264b′ or controlling knobs35aand/or36aofpumps35 and36, respectively. The amount of cardioplegia delivered during a given increment will be displayed on an updated basis in the middle of button264b′. To reset the volume delivered display to a full bolus amount (e.g., after the dispensation of an incomplete bolus of cardioplegia), a user may push “Reset” button264b″. As shown in FIG. 30I, an animated light indicator may be provided to indicate when cardioplegia is being delivered (e.g., indicated via green illumination) and when delivery is stopped (e.g., indicated via red illumination).
• “Test CPG Connection” button, when depressed, holds cardioplegia[0265]patient line valve96 open, so that distal pressure may be read oncardioplegia pressure sensor18.Valve96 must not be left open for an extended period of time because there is a danger of draining the patient through the CPG patient line. Therefore, button “Test CPG Connection” should operate as a press-and-hold (meaningvalve96 only stays open while the user is holding the button down) and/or logic must be included to automatically shut the valve after a predefined time (e.g., 3-5 seconds).
• “Cardioplegia Delivery Mode” region with “Antegrade” button[0266]264c′ and “Retrograde” buttons264c″: Buttons264c′ and264c″ provide a user with the ability to select different alarm limits for the pressure in tubing line156 (e.g., via sensing by pressure sensor18) when cardioplegia is in either antegrade and/or retrograde mode, respectively. In addition, the buttons may tell the system to use a different pressure sensor for alarming and/or limiting cardioplegia flow (e.g., use line pressure for Antegrade, coronary sinus pressure for Retrograde).
• The “Timers” row of graphic touch screen buttons can be configured to provide a user with various display options. For example, in the embodiment of FIG. 30I the following features are presented:[0267]
• “On Bypass” timer[0268]266a′: Timer266a′ provides for the automatic display of a timed duration that a patient is on-bypass. Timer266a′ may be automatically started whenarterial pump31 is operated after priming and pre-bypass filtering withvalve92 open. Timer266a′ will automatically stop whenarterial pump31 is stopped, withvalve92 closed, and will automatically start again whenpump31 is restarted withvalve92 open (e.g., with the timer beginning where it left off). The user may also manually start the On-Bypass timer simply by depressing button266a′, whereupon the timer will start. To stop the timer, a user may inactivate button266a′ via contact. To reset the timer, a user may contact button266a″.
• “X-Clamp” button[0269]266b′ and timer with “reset” button266b″: Button266b′ provides a user with the ability to time the duration the patient has been cross-clamped during a bypass procedure. To do so, a user may simply depress button266b′, whereupon the timer will start. To stop the timer, a user may inactivate button266b′ via contact. To reset the timer, a user may contact button266b″.
• “Off-Bypass” timer[0270]266c′: Timer266c′ may be provided to provide a user with a timed duration display showing the amount of time that a given patient has been off bypass. Timer266c′ may be automatically started whenvalve92 is closed, and may automatically stop whenvalve92 is reopened. Timer266c′ will automatically reset when started again. The user may also manually start the Off-Bypass timer simply by depressing button266c′, whereupon the timer will start. To stop the timer, a user may inactivate button266c′ via contact. To reset the timer, a user may contact button266c″.
• “Auxiliary” timer[0271]266d′ with “reset” button266d″: Button266d′ and reset button266d″ are provided to allow a user to selectively time any given procedure being conducted during a procedure. To initiate the timer, button266d″ may be contacted by a user. To stop the timer, button266d″ may again be contacted so as to deactivate the timer. To reset the time to zero, reset button266d″ may be contacted. When bypass is complete, the user may press the navigational button
• “Go to Post Bypass” to move to the Post-Bypass screen described in FIG. 30J.[0272]
• Post-Bypass:[0273]
• As shown in FIG. 30J, “Main”[0274]tab242 now shows the Post-Bypass screen, which is similar to the Bypass except for the User Defined row of buttons and the navigational buttons. The User Defined buttons are defined as follows:
• “Fill Patient” region with “Bolus” button[0275]264d′ and “Deliver” button264d″: Button264d′ provides a user with the ability to set a targeted amount of blood bolus to be dispensed to a patient viatubing line122. Upon contacting button264d′ a user may utilizecontrol knob52 to establish the desired amount of bolus to be delivered. The center of button264d′ will present the selected amount. To exit the adjustment mode button264d′ may again be pushed orcontrol knob52 may be pushed. In order to initiate the delivery of a bolus amount, a user may simply contact button264d″. Button264d″ includes an illuminated display to show the amount of bolus that has been delivered during a bolus delivery period. To stop bolus delivery, a user may contact button264d″ so as to trigger an inactive state. Alternatively, a user may manually stop the delivery of bolus via manual stoppage ofpump31, or just start/stop manually within using the bolus control logic.
• “Chase” region operates similarly to Fill Patient, but activates an additional algorithm whereby as fluid is removed from the[0276]venous reservoir108 the prime bag valves are opened to let priming solution in to maintain the initial reservoir level (when Chase was initiated), thereby “chasing” blood out of the reservoir with saline.
• “To Bags”: This button adds an additional mode to the Fill Patient and Chase modes, whereby instead of “filling” or “chasing” blood down the arterial[0277]patient line122, the arterial line valve stays closed, and the user connects a transfer bag and/or hemoconcentrator to the stopcock provided for such, and then the system is “filling” or “chasing” blood to the bag/hemoconcentrator.
• The navigational button “Return to Bypass” will move back to the Bypass screen described in FIG. 30I. The navigational button “Move to Unloading” will move forward to the Unload screen described in FIG. 30K.[0278]
• Unload:[0279]
• When the “Move to Unloading” button is pushed by user, the[0280]first tab242 will present an “Unload” title with the corresponding procedure-related information presented incontext portion243, as illustrated in FIGS.30K-30L. In thecontext portion243 of the “Unload” tab screen steps are included:
• “Clamp prime and cardioplegia bag lines.” Together with this narrative, a graphic depiction is provided corresponding with[0281]crystalloid tubing lines133 andprime bag lines160 so as to prompt a user to clamp off the bag lines before the cartridge is disengaged from the platform.
• “Remove pump loops.” Together with this narrative, a graphic depiction is presented that corresponds with a tubing loop (e.g.,[0282]110,178,190,180,132 or140) positioned within a pump assembly (e.g.,31,32,33,34,35 or36), so as to prompt a user to remove all tubing loops from the pumps.
• “Unload cartridge.” Of note, this step is presented in the form of a graphic button having touch screen capabilities, wherein a user may simply contact the button so as to cause[0283]cartridge120 to be automatically advanced away from the machine or loadingassembly21 to be automatically retracted away from thecartridge120, and to causeoxygenator112 to be automatically advanced away from the machine ormoveable carriage member511 to be automatically retracted away from thestationary face plate510. In this regard, the message block245 comprises the directive “Complete steps below, then press ‘Unload cartridge and oxygenator.’” While unloading is progressing, message block245 may automatically display a series of messages indicating the automatic configuration steps being completed bycontrol unit10.Block245 may also include a graphic progress bar that automatically fills an outlined region in corresponding relation to the degree of completion of task (e.g., as determined by a comparison of elapsed time to a predetermined or predicted time for completion). When this step is completed, a graphic check-mark will be presented within the “Unload Cartridge and Oxygenator” button, so as to indicate to the user that the step has been successfully completed, as shown in FIG. 30L.
• The navigational button “Post-Bypass” in FIG. 30K will be presented before the cartridge is unloaded, to allow the user to move back to the Post-Bypass screen in FIG. 30J. The button will be hidden after the cartridge is unloaded (as shown in FIG. 30L), unless it is reloaded by pressing “Unload cartridge” again.[0284]
• The navigational button “Set-Up” in FIG. 30L will be presented after the cartridge is unloaded, and allows the user to move back to the beginning screen for a new case (FIG. 30A).[0285]
• AV Tab:[0286]
• As previously noted, the “A-V”[0287]tab244 provides for the pictorial depiction of components of the venous and arterial fluid circuits and interfacing flow control and sensor components ofcomponent interface region12, as well as a plurality of touch screen control buttons. As shown in FIG. 31A, the context drivenportion243 of the “A-V”tab244 comprises a column of touch screen buttons262a′-262e′ in afirst sub-region267, and a fluid circuit illustration insub-region268. Buttons262a′-262e′ provide for direct user access to the same functionalities described above in corresponding relation to buttons262a-262eof FIG. 30I.
• With particular reference to the[0288]fluid circuit sub-region268, it can be seen that a number of graphic objects corresponding with components of the arterial-venous circuit defined bydisposable assembly100 are graphically depicted together with graphic objects corresponding with selected flow control and sensing components provided bycomponent interface region12. The various graphic objects are presented with fluid flow lines therebetween having arrowheads to indicate the direction of fluid flow. The fluid flow lines are color-coded to indicate venous circuit blood flow (e.g., indicated by use of blue fluid flow lines) and arterial circuit blood flow (e.g., indicated by use of red fluid flow lines). As will be further described, certain of the graphic objects have touch screen functionality.
• In particular, the objects entitled “Venous Assembly”[0289]270a, “Oxygenator”270b, “Arterial Filter Assembly”270cand “Air Shunt”270dmay be contacted by a user to provide additional detail regarding the various corresponding components. More particularly, FIG. 31B illustrates the further componentry that will be visually represented upon contact with each of the three noted objects. Such additional componentry is shown in FIG. 31B corresponding with those described in relation to thedisposable assembly100 andcomponent interface region12 descriptions hereinabove. Of note, it can be seen that the pictorial representations corresponding with various valve assemblies are illustrated in a manner that indicates whether valve assemblies are in an open or closed state. Further in this regard, it is important to note that the visual depictions of at least some of the valve assemblies are provided with touch screen functionality (e.g., as indicated by a three-dimensional depiction), wherein upon contact with a given one of such graphic representations, the corresponding valve assemblies within thecomponent interface region20 will automatically change its open or closed state to the opposite state (e.g., if opened upon contact the flow control assembly will close), unless such change of state would present a predetermined undesired condition in which case a change of state would not be effected. In the latter case, a pop-up window may appear describing why the change of state requested would be undesirable, but also allowing the operator to override this constraint and cause the valve to move anyway. Such functionality provides a user with the capability to selectively, manually control the flow of fluids through the system by effectively interfacing only withdisplay54.
• Level Pop-Up:[0290]
• The venous reservoir object[0291]270ecorresponding withvenous reservoir106 is also provided with touch screen functionality. More particularly, FIG. 31C illustrates a pop-upinterface window272 that will be presented upon contact with the venous reservoir object270e. Such window may be utilized to establish the desired level of fluid to be maintained in venous reservoir. Such pop-upwindow272 also allows a user to specify whether the desired level is to be maintained by automatic operation of thearterial pump31, by thevenous line clamp46 withincomponent interface region20, or by the vacuum regulator described in FIG. 11.
• More particularly, as illustrated in FIG. 31C the pop-up[0292]window272 comprises the following touch screen buttons (one and only one of the four level control buttons272a,272b,272f, and272gwill be presented in a depressed state, to show the current mode of level control):
• “Art Pump” button[0293]272aallows a user to readily select the option of having the desired fluid level invenous reservoir106 established or maintained via automatic operation ofarterial pump31. Upon activation, button272awill be presented in a depressed state. To deactivate, “Off” button272gmay be contacted so as to turn level control off.
• “VLC” button[0294]272ballows a user to readily select the option to have the desired fluid level invenous reservoir106 established or maintained by the automatic operation ofvenous line clamp46. Upon activation, button272bwill be presented in a depressed state. To deactivate, “Off” button272gmay be contacted so as to turn level control off.
• “Vacuum” button[0295]272fallows a user to readily select the option to have the desired fluid level invenous reservoir106 established or maintained by the automatic operation of the vacuum regulator, when Vacuum-Assisted Venous Drainage (VAVD) is being used. Upon activation, button272fwill be presented in a depressed state. To deactivate, “Off” button272gmay be contacted so as to turn level control off.
• “Off” button[0296]272gis used to stop level control by any method. When no level control mode is active, button272gwill be presented in a depressed state.
• “Level control=reservoir level” button[0297]272callows a user to automatically set the desired fluid level forreservoir106 to be whatever the then-current level is withinreservoir106. As such, upon activation of button272c,level sensor87 in thecomponent interface region12 ofunit10 will detect the current fluid level inreservoir106 and such fluid level will be utilized for purposes of automatic operation ofarterial pump31 orvenous line clamp46.
• “Settings” button[0298]272dmay be utilized by user as a shortcut to a screen for establishing various sensor settings corresponding withreservoir106. For example, high level and low level settings may be set by a user and monitored by the system to provide for automated system response and the provision of alarm messages as discussed hereinabove. The establishment of settings will be further described hereinbelow.
• Level control button[0299]272emay be utilized by a user to establish the desired fluid level to be maintained inreservoir106. In particular, the user may activate272eand then utilizecontrol knob52 to raise or lower the level control point. Asknob52 is manipulated, the level control button272ewill go up and down relative toreservoir106 to provide a visual indication of the desired level point. Additionally, the center of level control button272ewill illuminate with the volume setting corresponding with the position of the level control button272erelative toreservoir106. Again, to exit adjustment mode, button272eorcontrol knob52 may be contacted.
• Pressure Pop-Up:[0300]
• If a pressure sensor is contacted on the graphic depictions in these tabs, an associated pressure sensor pop-up window is displayed. For example, if the arterial pressure sensor on FIG. 31B is touched, the pop-up window shown in FIG. 31D is displayed. This pop-up allows the user to see the pressure limit and control settings, directly turn pressure control on or off for this sensor, or go to the full pressure sensor settings page (FIG. 33D) described hereinbelow by pressing the “Settings” button.[0301]
• Temperature Pop-Up:[0302]
• If a temperature sensor is contacted on the graphic depictions in these tabs, an associated temperature sensor pop-up window is displayed. For example, if the venous temperature sensor on FIG. 31B is touched, the pop-up window shown in FIG. 31E is displayed. This pop-up allows the user to see the temperature limit settings, or go to the full temperature sensor settings page (FIG. 33E) described hereinbelow by pressing the “Settings” button.[0303]
• Sat/Hct Pop-Up:[0304]
• If the Sat/Hct sensor on FIG. 31B is touched, the pop-up window shown in FIG. 31F is displayed. This pop-up duplicates the front panel of the standalone Sat/Hct device, allowing the user to standardize and calibrate the device, or go to the full Sat/Hct sensor settings page (not shown) by pressing the “Settings” button.[0305]
• CPG Tab:[0306]
• Referring now to FIG. 32A,[0307]CPG tab246 and its corresponding display are illustrated. As noted above, the CPG tab display provides information relating to the cardioplegia circuit defined by various components of thedisposable assembly100 as well as interfacing components ofcomponent interface region12. Thecontext region243 of the CPG tab screen comprises afirst sub-region267 that includes various touch screen, graphic buttons and asecond region268 that provides a visual representation of the cardioplegia circuit with objects corresponding with various components ofdisposable assembly100 andcomponent interface region12 graphically represented. In this regard, it can be seen that thecircuit illustration region268 comprises the following graphic objects: “CPG Cardio Outlet Assembly”274band “Totals”274c. Each of these objects may be contacted by a user to access a more detailed illustration of pictorial presentations of corresponding components of thedisposable assembly100 andcomponent interface region20, as shown in FIG. 32B. The graphic objects noted above are interconnected with fluid flow lines having arrows indicating the direction of fluid flow therebetween. Such fluid flow lines may be color coded in a manner to indicate the type of fluid (e.g., yellow fluid flow line indicates crystalloid and cardioplegia mixture flow and red fluid line indicates arterial blood fluid flow).
• As noted the[0308]CPG tab246 shown in FIG. 32A also includes a number of pictorial representations corresponding with various components of thecomponent interface region20. Such pictorial representations correspond withcardioplegia crystalloid pump36,cardioplegia blood pump35,pressure sensor18 andcontrol valve assembly96.Valve assembly96 representation is provided with touch screen capabilities to permit opening and closing ofvalve96 upon contact. The CPG tab screen shown in FIG. 32A may include animated representations corresponding with cardioplegiacrystalloid bags136. In this regard, the volume contents within each of thebags136 may be monitored on an on-going basis via interface of the embedded processor withcrystalloid pump36 wherein volumetric contents may be represented graphically and numerically in the pictorial representations of thecrystalloid bags136.
• Referring now to the[0309]first sub-region267 shown in FIG. 32A, it can be seen that a plurality of graphic object buttons are presented. Several of these buttons correspond in type and functionality with the second row of graphic object buttons presented in the “Main” tab screen illustrated in FIG. 30I. Additionally, of importance, a graphic button entitled “Ratio”276 is presented which indicates the ratio of blood to crystalloid solution to be established for the cardioplegia fluid delivered to a patient utilizing the current settings. In the event that a user would like to selectively change such ratio at any time, the “Ratio” touch screen button276 may be contacted and the user may then utilizecontrol knob52 to increase or decrease the ratio to the desired level (as shown in FIG. 32B), which will take effect immediately if a bolus is currently in progress. Pushing in thecontrol knob52 or pushing or touching another area on the touch screen will exit the adjustment mode. Buttons464a,464b′ and464b″, and464c′ and464c″, operate in the same functional manner as described above in relation to buttons264a,264b′ and264b″,264c′ and264c″, respectively. Further, the “Deliver Blood Only” button in FIG. 32A allows the user to deliver cardioplegia blood continuously (non-bolused) through only thecardioplegia blood pump35, with no crystalloid added (non-ratioed), until the “Deliver Blood Only” button is touched again to terminate the blood only mode.
• As noted above, the “CPG Cardio Outlet Assembly” object[0310]274band “Totals” object274cof the CPG tab screen shown in FIG. 32A may be contacted by a user. FIG. 32B illustrates the additional information that would be conveyed upon contact with each of the two objects.
• Suction/Fluids Tab:[0311]
• Continuing now to FIG. 32C, the “Suction/Fluids” tab screen and corresponding context driven[0312]display region243 is presented.Region243 provides graphic representations corresponding with a firstsuction tubing line170 andcorresponding pump32, thesecond suction line172 andcorresponding suction pump34 and the leftventricle tubing line186 andcorresponding pump33, along with the three negative pressure sensors associated with these three suction/vent lines. Also depicted are the sequestration reservoir and sequestration drain valve, the two valves that direct the vent pump to either reservoir, and prime bags and associated prime bag valves, and the reservoir filter pressure sensor.
• In the alternative circuit embodiment shown in FIG. 3B, a modified user interface could contain the following buttons (not shown):[0313]
• “Hemoconcentrator to Reservoir” button allows a user to initiate automated hemoconcentration, wherein upon contacting the button pumps[0314]37 and38 will operate at pre-selected rates to pump the hemoconcentrated blood toreservoir106.
• “Hemoconcentrator to Transfer Bag” button allows a user to initiate automated hemoconcentration, wherein upon contacting the button pumps[0315]37 and38 will operate at pre-selected rates to pump the hemoconcentrated blood to transfer bag194.
• “Transfer Bag to Reservoir” button allows a user to selectively initiate the flow of fluid from transfer bag[0316]194 toreservoir106.
• “Reservoir to Transfer Bag” button: This button allows a user to selectively effect the transfer of fluid from[0317]reservoir106 to transfer bag194.
• “Off” button allows a user to stop any and all of the functions associated with the four buttons listed above.[0318]
• Gases Tab:[0319]
• FIG. 32D illustrates the “Gases”[0320]tab250 and a corresponding context drivenregion243. Again the context drivenportion243 includes afirst sub-region267 with a plurality of touch screen buttons468a-468c, and asecond sub-region268 which presents a visual representation of a gascircuit servicing oxygenator112.
• Waveforms Tab:[0321]
• FIG. 32E illustrates the “Waveforms”[0322]tab252 and corresponding context drivenregion243. Again, the context drivenportion243 includes afirst sub-region267 with a plurality oftouch screen buttons282a-282c, and asecond sub-region268 which presents a visual representation of one or more monitored waveforms. More particularly, button282amay be contacted to access a screen which allows the user to select sensors for which corresponding monitored waveforms are to be presented. The user may select from a plurality of sensors, including for example, sensors to monitor a patient's temperature, blood pressure and ECG readings. Upon selection of a sensed parameter for waveform presentation, the user may utilize buttons282band282cto enlarge and reduce, selectively, a given portion of the presented waveforms.
• FIG. 32E also shows a “Backward” button, that, for trending waveforms, allows the user to display waveform activity earlier in time than that currently shown, and a “Forward” button that allows the user to return forward to the waveforms showing data currently being collected.[0323]
• Settings Tab:[0324]
• Finally, FIGS.[0325]33A-33F illustrate the “Settings”tab254 and corresponding context drivenregion243 options accessible to a user. In particular, the context-drivenportion243 shown in FIGS.33A-33F includes afirst sub-region284 comprising a row of touch screen buttons, and asecond sub-region286 which provides a listing of further touch screen options corresponding with theparticular button284a-284fwithinsub-region284 that has been contacted by user.
• Protocol Settings:[0326]
• For example, FIG. 33A shows a[0327]second sub-region286 that would be presented upon contact with the “Protocol” button284apresented in thefirst sub-region284. A “Protocol” is a named, stored set of all the parameter settings that may be established by the user through the settings pages described hereinbelow. This includes all sensor limit settings, configuration of user-defined and configurable sections of the screen, and all other settings from these screens. The “Current Protocol” item286aat the top ofsub-region286 indicates the name of the last protocol that was established for current use (“Loaded”), and will also have a asterisk next to it if any parameters settings have been modified since the last protocol was loaded. Such setting modifications are temporary, and will be overwritten if another (or the same) named protocol is loaded. Such temporary settings may save into a new or existing protocol with the “Save Protocol” control286edescribed below.
• The touch screen options presented in the[0328]second sub-region286 allow a user to select a protocol set to establish upon power-up of the machine (the “Wake-Up” protocol286b), establish a different named protocol to be used currently (“Load Protocol”286c), examine the details of any named protocol (“Display Protocol”286d), and save the current settings as a new named protocol (“Save Protocol”286e). Contacting the down arrow (286b′,286c′,286d′,286e′) to right of each of these four controls displays what is known as a “pull-down list”, which drops down on top of whatever is below, and provides a scrollable list of all currently saved named protocols, including one or more “Factory Default” protocols which are pre-set at the factory, and may not be modified. Selecting a protocol from one of these four lists causes the named protocol to be established as the Wake-Up protocol, loaded as the current protocol, have its parameters displayed, or be overwritten with the current parameter settings, respectively. Additionally, the “Save Protocol” pull-down list will have an item called “New”, which, when selected, will allow the user to save a new protocol, and give it a new name using an externally connected or on-screen alphanumeric keyboard.
• Sensor Settings:[0329]
• In order to adjust individual component settings, a user may contact one or more of the other buttons of the[0330]first sub-region284. For example, upon contact with the “Sensors” button284brepresented in the first sub-region, the options set forth in FIG. 33B will be presented. In this regard, and as shown in FIG. 33B, the various sensors may be grouped as follows: “air detectors”, “pressure sensors”, “level detectors”, “blender/gas”, “temp. sensors” and “SAT/HCT”. The various sensors that correspond with each of these categories may be presented via contact with an adjacent down arrow button, wherein a full listing of the various sensors comprising a given group will be listed, each with corresponding buttons. This is demonstrated in FIG. 33C with the air detectors pull-down list. The user may then contact the graphic button corresponding with a given sensor to establish the desired settings. By way of example, FIG. 33D illustrates the display accessible when a user contacts the button for “Arterial Line” pressure sensor, and FIG. 33E illustrates the display accessible when a user contacts the button for “Venous” temperature sensor.
• Pressure Sensor Settings:[0331]
• As shown in FIG. 33D, a number of arterial pressure settings can be established. In particular, the display corresponding with FIG. 33D provides for establishing four different, predetermined pressure settings to be monitored by[0332]pressure sensor14. In order to modify a given setting, a user may simply contact the corresponding set button (e.g., the “low warning”) button and then establish the desired setting viacontrol knob52. As thecontrol knob52 is adjusted, the corresponding pressure setting button will move along the depicted pressure scale. When the desired pressure setting has been reached, a user may again push the corresponding pressure setting button orcontrol knob52. In addition to setting the desired pressure levels, a user may further select from a variety of sensor control functions as indicated by the various touch screen buttons.
• Temperature Sensor Settings:[0333]
• As shown in FIG. 33E, a number of venous temperature settings can be established. In particular, the display corresponding with FIG. 33E provides for establishing high and low alarm limit settings to be monitored by the venous temperature sensor in[0334]venous entry module108. Settings methods and options are similar to those described for FIG. 33D.
• As will be appreciated, similar screens may be provided for establishing the settings of and control over the operation of the various other types of sensors comprising[0335]control unit10, and generally noted by the groups indicated by FIG. 33B.
• CPG Settings:[0336]
• FIG. 33F-CPG Settings (accessed from CPG button[0337]284con Settings tab FIG. 33A) gives the ability to specify the constituents, starting volume, and default ratio for the crystalloid bags, and change the bolus mode between volume, time or continuous, count up or count down, as well as other settings.
• More Settings (Not Shown):[0338]
• Timers button[0339]284don Settings tab FIG. 33A accesses a Timer Settings screen that gives timer on/off time/date tracking history, and the ability to set timer alarms.
• Pulse button[0340]284eon Settings tab FIG. 33A accesses a Pulsatile Flow Settings screen that lets the user set the Pulsatile flow parameters for the arterial pump, such as BPM, duty cycle, and baseline flow.
• Other button[0341]284fon the Settings tab FIG. 33A accesses a Miscellaneous Settings screen that lets the user set the system date and time, language to use, and other miscellaneous settings.
• VIII. Summary of Control Protocols and Algorithms[0342]
• The perfusion system uses automated procedures described below.[0343]
• 1. Auto Prime[0344]
• The “Auto-Prime” procedure, initiated by contacting[0345]graphic button260c′ on the “Auto-Prime” tab screen shown in (FIG. 30D) will result in the automatic priming of the venous, arterial and cardioplegia fluid circuits. As will be appreciated, the automatic priming will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• Such steps will include the opening/closing of the[0346]priming solution valves98 so as to cause the priming solution to flow through theintegral passageway164 ofcartridge120 andline129 into thevenous reservoir106 and fill thevenous reservoir106 to a predetermined volume. Operation of thearterial pump31 and the opening/closing of the various valve assemblies oncontrol unit10 will be completed according to the predetermined protocols so as toprime line110,oxygenator112,line116,arterial filter118, arterialpatient line122, venouspatient line104,venous entry module108,pre-bypass filter168,line166 and the airpurge tubing line119a, integral passageways309aand309bofcartridge120, and line119b.
• In this regard, it should be noted that the[0347]disposable assembly100 will initially provide for a fluid interconnect between arterialpatient tubing line122 andvenous tubing line104, wherein the priming solution may flow throughpatient tubing line122,connector175 and intovenous tubing line104. As will be appreciated,venous line clamp46 andvalve assembly95 may be employed to direct the priming fluid throughtubing lines166 and104 for priming purposes.Connector175 will be disposed for selective removal after priming when patient interconnect for bypass is desired.
• The automatic priming protocol will include inverting the[0348]arterial filter118 and reinverting thearterial filter118 to the up-right position multiple times during the priming sequence to facilitate priming and removing air from the arterial filter. As priming of thearterial filter118 is initiated, the filter will be inverted by rotating mountingarm762 as previously described herein such that the inlet fromline116 and air purge outlet connecting to line119aof the arterial filter is down, and the outlet connecting toline122 of the arterial filter is at the top. During the bypass procedure the arterial filter inlet and air purge outlet are located on the top of the arterial filter and the outlet is located at the bottom of the arterial filter. As previously described, initially during the automatic priming procedure the arterial filter is inverted. Flow enters the arterial filter from the inlet and due to the inverted positioning of the arterial filter the flow fills the arterial filter from the bottom up forcing air to naturally rise to the top of the arterial filter and out the outlet of the arterial filter. At some point after the arterial filter has been primed in the described manner the arterial filter is reinverted to the up-right position where air in the arterial filter can rise to the top and be purged outline119a. The inverting and reinverting to the upright position is repeated multiple times at high and/or low flow rates to ensure the arterial filter is completely primed and air is removed.
• Automatic priming will also entail the selective operation of[0349]cardioplegia blood pump35,cardioplegia crystalloid pump36,arterial pump31 and the selective opening/closing of appropriate valves comprisingcontrol unit10 so as to direct priming solution fromvenous reservoir106 throughtubing line128, andintegral passageway130. Such operation will effect priming of the cardioplegia circuit portion includingintegral passageways142, and150,tubing lines146,cardioplegia heat exchanger148,bubble trap152 as well astubing loop132. Similarly, thecardioplegia tubing line156 will be primed throughconnector175 fluidly interconnected withvenous line104 and returning fluid tovenous reservoir106. Similarly, the cardioplegia crystalloid circuit includingcrystalloid lines133,integral passageways138, and142, andtubing loop140 will be primed with crystalloid solution.
• 2. Pre-Bypass Filter[0350]
• After the “Auto-Prime” procedures, a user may contact the “Pre-Bypass Filter”[0351]button260c″ illustrated in (FIG. 30H), thereby causing the priming solution present in the arterial-venous circuit to be filtered via passage throughpre-bypass filter168 for a user selected time at a user selected flow rate by operation ofarterial pump31. In particular,valve46 will close andvalve95 will open, thereby diverting priming solution which flows into venous entry module to flow through thepre bypass filter168 andline166 intovenous reservoir106. The priming solution may then circulate fromvenous reservoir106 throughtubing lines110,116, and122, and through theconnector175 that interconnects arterialpatient line122 andvenous line104, throughvenous entry module108 and back topre-bypass filter168.
• Additionally, while pre-bypass filtering described herein above, the[0352]cardioplegia blood pump35 may be operated causing the priming solution in the cardioplegia circuit to flow throughpre-bypass filter168. In particular,cardioplegia blood pump35 may be operated andvalve96 opened thereby causing the priming solution to be diverted throughline128,integral passageways130,142,150;tubing lines146,pump tubing loop132,cardioplegia patient line156, throughconnector175, and into thevenous line104 for return to thepre-bypass filter168.
• 3. Start/Stop Bypass[0353]
• To initiate bypass, the various cannula assemblies provided on[0354]cardioplegia tubing line156,venous tubing line104 andarterial tubing line122 may be located as appropriate within the body cavity of the patient.
• Thereafter, to initiate actual bypass blood flow,[0355]venous line clamp46 may be manually operated by contactinggraphic button222aor button222band adjustingknob52 to initiate and sustain the necessary flow of venous blood throughtubing line104 tovenous reservoir106.Arterial pump31 may also be manually operated by adjustingknob31aand automatically or manually openingvalve92 to initiate and sustain the necessary flow to return blood to the patient through arterialpatient line122.
• Additionally, while a user may start or stop a bypass procedure via manual control of[0356]venous line clamp46 andarterial pump31 andvalve92, a user may initiate an automatic start or stop bypass procedure. The automatic start procedure, initiated and/or enabled by contacting a graphic button (not shown) onuser interface50, will result in the automatic start of thearterial pump31 and/or the automatic opening of thevenous line clamp46. As will be appreciated, the automatic start procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. Thecontrol unit10 may then begin automated start or automated stop of the bypass procedure if the procedure is currently in progress. For example, at the outset of bypass, the starting up ofarterial pump31 is controlled according to a predetermined ramp rate protocol. Such ramp rate, the speed or flow increase per unit time, may be selected by a user by contacting graphic buttons (not shown) and/or adjustment ofknob52 onuser interface50tab254. Similarly, at the outset of bypass, the opening of thevenous line clamp46 may occur according to a predetermined ramp rate protocol stored in memory after contacting a graphic button (not shown) onuser interface50. Such ramp rate, the opening rate per unit time, may be selected by a user by contacting graphic buttons (not shown) and/or adjustment ofknob52 onuser interface50.
• The automatic/manual operation described herein above of the[0357]venous line clamp46 andarterial pump31 to start bypass may occur in any combination. More specifically bypass may be initiated by manual operation of both thevenous line clamp46 andarterial pump31, manual operation of thevenous line clamp46 with automatic operation of thearterial pump31, automatic operation of thevenous line clamp46 with manual operation of thearterial pump31, or automatic operation of both thevenous line clamp46 andarterial pump31.
• The manual/automatic methods herein described above to start bypass may be similarly used to stop the bypass procedure. More specifically, the[0358]venous line clamp46 may be manually operated to reduce or terminate the flow of blood from the patient and thearterial pump31 may be manually operated to reduce or terminate the flow of blood to the patient as necessary to stop bypass. Similarly, the automatic means to start bypass through the automatic operation of thevenous line clamp46 and thearterial pump31 may be used to stop bypass using the ramp methods described herein above to reduce or terminate the blood flow to or from the patient as necessary to stop bypass. The manual and automatic ramp methods of operating thevenous line clamp46 andarterial pump31 described herein above to start or initiate bypass may also be used in the same combinations as described herein above to reduce or terminate flow as necessary to stop bypass.
• 4. Auto Start/Stop Bypass Using Venous Line Clamp to Control Venous Reservoir Level[0359]
• This is a method of either starting or stopping bypass while maintaining the[0360]venous reservoir106 level at a pre-selected value through increasing or decreasing the amount of restriction of thevenous line104 usingvenous line clamp46 control. More specifically, prior to initiating bypass, the user would select the desired venous reservoir level to maintain while starting bypass by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50. The pre-selected venous reservoir level could be set to the current reservoir level, or a reservoir level either above or below the current level as desired by the user. The venous line clamp reservoir level control procedure, initiated and/or enabled by contacting a graphic button (not shown) onuser interface50, will result in venous reservoir level control by automatic opening or closing ofvenous line clamp46. As will be appreciated, the automatic level control will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• As bypass is started, the user would manually operate the[0361]arterial pump31 to begin bypass flow and slowly or quickly increase flow to the user desired flow rate. While the user started flow by increasing the speed through operation ofknob31aonarterial pump31, thevenous line clamp46 would automatically begin to open to the amount necessary to maintain thevenous reservoir106 level at the pre-selected value. As the venous reservoir level fluctuates either due to adjustment of thearterial pump31 flow rate or due to other volumetric changes in the patient or bypass circuit,venous line clamp46 would automatically increase or decrease the amount of restriction invenous line104 to either increase or decrease the flow into the venous reservoir to maintain the venous reservoir level at the pre-selected value.
• Conversely, in order to stop bypass, the venous line clamp reservoir level control procedure, initiated by contacting a graphic button (not shown) on[0362]user interface50, will result in venous reservoir level control by automatic opening or closing ofvenous line clamp46. Prior to stopping bypass, the user would select the desired venous reservoir level to maintain while stopping bypass by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50. While the user decreases the flow by reducing the arterial pump flow rate through operation of theknob31aonarterial pump31, thevenous line clamp46 would automatically begin to close to the restriction necessary to maintain thevenous reservoir106 level at the pre-selected value. As the venous reservoir level fluctuates either due to continued slow down of thearterial pump31 flow rate or due to other volumetric changes in the patient or bypass circuit,venous line clamp46 would automatically decrease or increase the amount of restriction invenous line104 to either increase or decrease the flow into the venous reservoir to maintain the venous reservoir level at the user pre-selected value.
• 5. Auto Start/Stop Bypass Using Arterial Pump to Control Venous Reservoir Level[0363]
• This is a method of either starting or stopping bypass while maintaining the[0364]venous reservoir106 level at a pre-selected value through increasing or decreasing the flow into and out ofvenous reservoir106 through automatic control ofarterial pump31 flow rate. More specifically, prior to initiating bypass, the user would select the desired venous reservoir level to maintain while starting bypass by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50. The pre-selected venous reservoir level could be set to the current reservoir level, or a reservoir level either above or below the current level as desired by the user. The arterial pump reservoir level control procedure, initiated and/or enabled by contacting a graphic button (not shown) onuser interface50, will result in venous reservoir level control by automatic increasing or decreasing flow ofarterial pump31. As will be appreciated, the automatic level control will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• As bypass is started, the user would manually begin to open[0365]venous line clamp46 to begin bypass flow and slowly or quickly increase venous flow to the user desired flow rate. While the user started flow by decreasing the restriction invenous line104 through manual operation ofvenous line clamp46, thearterial pump31 would automatically begin to increase flow to the amount necessary to maintain thevenous reservoir106 level at the pre-selected value. As the venous reservoir level fluctuates either due to adjustment ofvenous line clamp46 or due to other volumetric changes in the patient or bypass circuit,arterial pump31 would automatically increase or decrease the amount offlow104 to either increase or decrease the flow out of the venous reservoir to maintain the venous reservoir level at the pre-selected value.
• Conversely, in order to stop bypass, the arterial pump reservoir level control procedure, initiated by contacting a graphic button (not shown) on[0366]user interface50, will result in venous reservoir level control by automatic increasing or decreasing flow by operation ofarterial pump31. Prior to stopping bypass, the user would select the desired venous reservoir level to maintain while stopping bypass by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50. While the user decreases the flow into thevenous reservoir106 by reducing the restriction invenous line104 through manual operation of thevenous line clamp46, thearterial pump31 would automatically begin to reduce flow to the amount necessary to maintain thevenous reservoir106 level at the pre-selected value. As the venous reservoir level fluctuates either due to continued restriction ofvenous line104 through operation ofvenous line clamp46 or due to other volumetric changes in the patient or bypass circuit,arterial pump31 would automatically decrease or increase the flow exitingvenous reservoir106 to maintain the venous reservoir level at the pre-selected value.
• 6. Cardioplegia Pressure Protection[0367]
• The “Cardioplegia Pressure Protection” procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0368]user interface50 will result in the automatic control of cardioplegia pumps35,36 to prevent negative pressure occurring onoxygenator112. As will be appreciated, the automatic cardioplegia pressure protection procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• If enabled, the cardioplegia pressure protection procedure may provide an automated monitoring function, wherein if the pressure in the[0369]arterial tubing line122, as monitored bypressure sensor14 falls below a predetermined low limit, thecardioplegia blood pump35 and/orcrystalloid pump36 will automatically slow down while maintaining their respective flow rate ratios such that the flow of thecardioplegia blood pump35 does not cause the pressure inline122 as monitored bypressure sensor14 to fall below a predetermined low pressure limit. Alternatively, if the pressure monitored bypressure sensor14 falls below a predetermined low limit, thecardioplegia blood pump35 and/orcrystalloid pump36 will automatically stop. Such automatic control reduces the risk that a negative pressure will act upon the membrane within theoxygenator112 so as to introduce air into the arterial blood. If the pressure monitored bypressure sensor14 falls below a predetermined low pressure limit an alarm will occur onuser interface50.
• 7. Cardioplegia-Arterial Pump Interlock[0370]
• The “Cardioplegia-Arterial Pump Interlock” procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0371]user interface50 will result in the automatic control of cardioplegia pumps35,36 to prevent negative pressure occurring onoxygenator112. As will be appreciated, the automatic cardioplegia-arterial pump interlock procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• If enabled, the cardioplegia-arterial pump interlock procedure may provide an automated monitoring function, wherein if the arterial pump stops or slows to a flow rate below the flow rate of the[0372]cardioplegia blood pump35, thecardioplegia blood pump35 and/or thecrystalloid pump36 may stop. Alternatively, if the arterial pump stops or slows to a speed or flow rate below the flow rate of thecardioplegia blood pump35, thecardioplegia blood pump35 and/or thecrystalloid pump36 may slow down to a combined flow rate, while maintaining their respective flow rate ratios, such that thecardioplegia blood pump35 flow rate is less than the arterialpump flow rate31. Such automatic control reduces the risk that a negative pressure will act upon the membrane within theoxygenator112 so as to introduce air into the arterial blood.
• 8. Post Bypass Fluid Recovery[0373]
• Upon completion of a bypass procedure, additional automated operations may be completed. For example, specific protocols may be followed to recover as much usable blood as possible from the fluid circuits. Such procedures may include the drainage of blood from a[0374]sequestration reservoir301 intovenous reservoir106 via selective control over valve401 by contacting a graphic button (not shown) onuser interface50. Additionally, a user may drain blood from thevenous tubing line104 into thevenous reservoir106 by openingvenous line clamp46 by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.Cardioplegia blood pump35 andarterial pump31 may also be selectively operated in reverse by contacting graphic buttons (not shown) onuser interface50 resulting in the automatic operation ofcardioplegia blood pump35 andarterial pump31 and cardioplegiapatient line valve96. As will be appreciated, the procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps by contacting graphic buttons (not shown) onuser interface50 as to empty the cardioplegia circuit blood throughintegral passageway130 totubing line128,arterial filter118,tubing lines116 and118, and back into thevenous reservoir106. The collected body fluid may then be diverted to a transfer bag throughvalve311 or throughline122 or through connection directly to an autologous blood salvage device for subsequent washing for later return to the patient.
• 9. Sequestration Level Sensing[0375]
• The “Sequestration Level Sensing” procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0376]user interface50, will result in the automatic control of suction and vent pumps32,33, and34 and/or sequestration drain valve401 to prevent over filling of the sequestration reservoir. As will be appreciated, the automatic sequestration level sensing procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• If enabled, the sequestration level sensing procedure may provide an automated function. If the[0377]lower level sensor322 detects fluid an advisory alarm occurs to alert the user that the level insequestration reservoir301 is rising. The user may then open drain valve401 and empty the contents through integral passageway305 andtubing line129 into thevenous reservoir106 or drain off contents to a transfer bag or cell washing device throughmanual valve303.
• If the[0378]higher level sensor320 detects fluid an advisory alarm occurs atuser interface50 indicating thatsequestration reservoir301 is full. The sequestration drain valve401 automatically opens causing the contents ofsequestration reservoir301 to flow intovenous reservoir106 until the fluid level drops below thelower level sensor322 or until all suction pumps are stopped. Alternatively, if the operator prefers that the sequestered blood not be automatically added to the venous reservoir, the suction pumps32 and43 could be selectively stopped automatically. Thevent pump33 could also be automatically stopped or the fluid re-routed to thevenous reservoir106 through integral passageway192bandline129 by openingvalve403 and closingvalve402.
• The user options described herein above could be selected by contacting graphic buttons (not shown) on[0379]user interface50 to enable the desired options.
• 10. Automatic Air Shunt[0380]
• The “Automatic Air Shunt” procedure will result in the automatic shunting of air through automatic control of[0381]arterial pump31 andvalves405 and406 to remove air from the circuit and prevent air from entering the patient. As will be appreciated, the automatic air shunt procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• When a predetermined small amount of air (i.e., small amount of air is a given volume of air in a given amount of time where most of the air would flow through the air[0382]shunt circuit line119a, integral passageways309aand optionally309band line119bwithout a significant amount of air entering the arterial filter then transiting the arterial filter medium and exiting the arterial filter), is detected atoxygenator bubble sensor114 the high flow arterialfilter purge valve406 and optionally the low flow arterialfilter purge valve405 opens and the air/fluid is routed throughline116,arterial filter118,line119a, integral passageways309aand/or309b, line119btovenous reservoir106. An alarm condition will be generated and displayed onuser interface50.Valve406 andoptionally valve405 remain open until a predetermined amount of time after no air is present at thebubble sensor114 to ensure that all air is removed from the circuit.
• When a predetermined large amount of air (i.e., large amount of air is a given volume of air in a given amount of time that would exceed the amount of air that could flow through the air[0383]shunt circuit line119a, integral passageways309aand optionally309band line119bresulting in a significant amount of air entering the arterial filter and transiting the arterial filter medium then exiting the arterial filter and potentially into the arterial patient line122), or a continuous amount of small air is detected atoxygenator bubble sensor114 the high flow arterialfilter purge valve406 and optionally low flow arterialfilter purge valve405 opens and the air/fluid is routed throughline116,arterial filter118,line119a, integral passageways309aand/or309b, line119btovenous reservoir106. Additionally,arterial pump31 slows to a flow that will not generate a pressure that exceeds a predetermined value as seen atpressure sensor114 andvalve92 is closed. An alarm condition will be generated and displayed onuser interface50. After a predetermined amount of time after no air is present atbubble sensor114valves406 andoptionally valve405 close. After the air condition has cleared,valve92 is opened and arterial pump speed returns to the pre-air flow rate either automatically or manually by the user. Alternatively, instead of slowing downarterial pump31,arterial pump31 may be stopped andvalve92 closed.
• In each case where the[0384]arterial pump31 is slowed or stopped andvalves405 and406 opened or closed, the user can override the automated procedure by contacting graphic buttons (not shown) onuser interface50 which returns the arterial pump and/or valves to their pre automatic air shunt condition settings.
• If the arterial line pressure as measured at[0385]pressure sensor14 is not sufficiently high enough to prevent retrograde flow of air throughpurge valves405 and406,valves405 and406 could be closed if the arterial line pressure falls below a predetermined value.
• In addition, when air is detected at[0386]bubble sensor114 blood cardioplegia delivery is automatically interrupted to prevent air from reaching the cardioplegia system if the amount of air exceeds a predetermined amount that could transition the arterial filter and potentially enter the cardioplegiablood supply line128.
• 11. Automatic Fill Patient[0387]
• The “Automatic Fill Patient” procedure, initiated and/or enabled by contacting graphic button[0388]264d″ onuser interface50 will result in the automatic control ofarterial pump31 and arterialpatient line valve92 to deliver preselect volume to the patient. As will be appreciated, the automatic fill patient procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the desired volume to transfer to the patient by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• If enabled, this protocol automatically returns fluid to the patient at a user-selected bolus volume and flow rate at the end of the procedure. The user initiates the auto fill procedure by touching the[0389]264d″ button at theuser interface50. This automatically causesarterial line valve92 in arterialpatient line122 to open andarterial pump31 to run at the user-selected flow rate set atcontrol knob31a. After the selected bolus volume is delivered thearterial pump31 stops andvalve92 is closed. As the bolus is delivered, the current, and/or accumulated amount can be displayed onuser interface50.
• 12. Positive and Negative Pressure Control[0390]
• The “Pressure Control” procedures, initiated and/or enabled by contacting a graphic button (not shown) on[0391]user interface50 will result in the automatic control of any pump to control the pressures in the respective pump circuits. As will be appreciated, the pressure control procedures will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the desired pressure control settings by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• This control protocol is useful to control pressure in various circuits in the perfusion system by controlling pump speed. This control algorithm may be used in any pump circuit. This is more desirable than stopping the pumps on an overpressure condition since a complete stop of the pump results in completely stopping fluid flow in the circuit and potentially creating vastly fluctuating pressures.[0392]
• This control protocol allows the pump to be controlled to a speed lower than its user-set speed in order to control to a programmable set point pressure. This pressure set point may be either positive (for arterial or cardioplegia pumps) or negative (for suction or vent pumps). The maximum pump speed is the user-set speed at[0393]pump knobs31a-36a. The pump will run at this speed unless the measured pressure increases over the set point pressure (or decreases below the set point for negative pressure control.). When measured pressure exceeds set point pressure a pressure control loop is enabled. Use of this control algorithm requires a pressure transducer calibrated in appropriate units, having an appropriate sample rate (i.e., 40 Hz).
• The monitored pressure is used as a feedback control parameter to automatically adjust pump speed to maintain pressure at the control point. In the event the monitored pressure falls outside of user set limits an alarm/indication may be provided at[0394]interface50 and/or the speed of one or more (e.g., both cardioplegia pumps simultaneously) is either increased or decreased in order to maintain the desired pressure. For example, the user may set at the user interface a high pressure limit of 150 mmHg, a low pressure limit of 20 mmHg and a control point of 100 mmHg. By utilizing the monitored pressure as a feedback control parameter the system will automatically adjust the speed of the pumps to maintain pressure at the control point. If the pressure exceeds for any reason the upper or lower limit an alarm is activated at the user interface.
• 13. Venous Reservoir Level Control by Arterial Pump[0395]
• The venous reservoir level control by arterial pump procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0396]user interface50 will result in the automatic control ofarterial pump31 to maintain the desired level or volume in the venous reservoir. As will be appreciated, the level control procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the desired venous reservoir level to maintain by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• This control protocol maintains the level in the[0397]venous reservoir106 at a pre-selected value by controlling the speed ofarterial pump31. The continuous level control is an operational mode by which the level of the reservoir is not allowed to increase above or decrease below the pre-selected value which can be adjusted by the user. Use of this mode requires that a continuous level sensor such as that described with respect to FIG. 12 is present on the system to provide feedback of the current level of fluid in the reservoir. The pump's maximum flow rate is set by the user atpump knob31a. As the level increases above or decreases below the pre-selected value, a software and/or hardware implemented PID (Proportional, Integral, Differential) servo slows the pump down or speeds up the pump and adjusts the pump speed to maintain the pre-selected reservoir level resulting in the flow rate out of the reservoir closely matching the flow into the reservoir. If the flow into the reservoir increases substantially, then the level may rise above the set point because the pump flow rate is limited by the setting of thepump knob31a.
• The advantage of this method of level control is that the level in the reservoir can be controlled to any level. The level can also be changed at any time and there will be a smooth transition between the old and new levels. Use of the pump continuous level control system also increases patient safety because it will prevent emptying of the[0398]venous reservoir106 in case of temporary user inattention.
• 14. Venous Reservoir Level Control by Venous Line Clamp[0399]
• The venous reservoir level control by venous line clamp procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0400]user interface50 will result in the automatic control ofvenous line clamp46 to maintain the desired level or volume in the venous reservoir. As will be appreciated, the level control procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the desired venous reservoir level to maintain by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• This control protocol maintains the level in the[0401]venous reservoir106 at a pre-selected value by controlling thevenous line clamp46. The continuous level control is an operational mode by which the level of the reservoir is not allowed to decrease below or increase above some pre-selected value which can be adjusted by the user. Use of this mode requires that a continuous level sensor such as that described with respect to FIG. 12 is present on the system to provide feedback of the current level of fluid in the reservoir. As the level increases above or decreases below the pre-selected value, a software and/or hardware implemented PID (Proportional, Integral, Differential) servo partially or completely opens or closesvenous line clamp46 to maintain the pre-selected reservoir level resulting in the flow rate into the reservoir closely matching the flow out of the reservoir.
• The advantage of this method of level control is that the level in the reservoir can be controlled to any level. The level can also be changed at any time and there will be a smooth transition between the old and new levels. Use of the venous line clamp continuous level control system also increases patient safety because it will prevent emptying of the[0402]venous reservoir106 in case of temporary user inattention.
• 15. Venous Reservoir Level Control by Venous Reservoir Vacuum[0403]
• The venous reservoir level control by venous reservoir vacuum procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0404]user interface50 will result in the automatic control of venous reservoir vacuum to maintain the desired level or volume in the venous reservoir. As will be appreciated, the level control procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the desired venous reservoir level to maintain by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• This control protocol maintains the level in the[0405]venous reservoir106 at a pre-selected value by controlling the level of vacuum in the venous reservoir. Typically, vacuum level control would most likely be used when vacuum is already in use for vacuum assisted venous drainage procedures in order for vacuum to have an effect on increasing or lowering level. The continuous level control is an operational mode by which the level of the reservoir is not allowed to decrease below or increase above some pre-selected value that can be adjusted by the user. Use of this mode requires that a continuous level sensor such as that described with respect to FIG. 12 is present on the system to provide feedback of the current level of fluid in the reservoir. As the level increases above or decreases below the pre-selected value, a software and/or hardware implemented PID (Proportional, Integral, Differential) servo increases or decreases the vacuum in the venous reservoir to maintain the preselected reservoir level resulting in the flow rate into the reservoir closely matching the flow out of the reservoir. If vacuum is not currently in use in the venous reservoir, the ability to reduce vacuum to lower the reservoir level would not exist. In this case vacuum reservoir level control would only be one sided whereby vacuum could only be added and used to increase the level in the reservoir level.
• The advantage of this method of level control is that the level in the reservoir can be controlled to any level. The level can also be changed at any time and there will be a smooth transition between the old and new levels. Use of the venous reservoir vacuum continuous level control system also increases patient safety because it will prevent emptying of the[0406]venous reservoir106 in case of temporary user inattention.
• 16. Automatic Fluid Shuttling[0407]
• The automatic fluid shuttling procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0408]user interface50 will result in the automatic control ofvenous line clamp46 to transfer a preselected volume of fluid to or from the bypass circuit to the patient during bypass. As will be appreciated, the automatic fluid shuttling procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the desired volume to transfer by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• To transfer fluid to the patient, the system control automatically senses the current level in the[0409]venous reservoir106 and causes thevenous line clamp46 to reduce flow by restricting the venous line and/or the arterial pump to increase flow by increasing the pump speed until the selected volume has been transferred to the patient. Either thevenous line clamp46 setting or thearterial pump31 flow setting mode is selectable by the user by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50. At completion of the volume transfer the venous line clamp and/or the arterial pump will return to their previous settings. To transfer fluid from the patient, the system control automatically senses the current level in the venous reservoir and causes thevenous line clamp46 to increase flow and/or thearterial pump31 to decrease flow until the selected volume has been transferred from the patient. Thevenous line clamp46 setting or thearterial pump31 flow setting, which ever mode was used, will return to the previous settings after completing the volume transfer.
• 17. Variable Minimum Reservoir Level[0410]
• The variable minimum reservoir level control procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0411]user interface50 will result in the automatic control ofarterial pump31 to a safe flow rate to prevent emptying the venous reservoir and ensure that air is not introduced into the venous reservoir outlet line. As will be appreciated, the variable minimum reservoir level procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• To ensure the[0412]venous reservoir106 is not emptied when operating at lower levels in the venous reservoir and to ensure that air is not introduced into the venousreservoir outlet line110 due to high flow rates causing air generation from vortexing or entrained air to enter the venous reservoir outlet, thearterial pump31 flow is automatically reduced as the venous reservoir level decreases. Typically, the automatic slow down ofarterial pump31 occurs at levels below 200 mt to 500 mt. For example, as the venous reservoir level decreases below 200 mt, the arterial pump would begin to reduce flow to a safe flow rate. As the level in the reservoir continues to decrease, the arterial pump flow would also continue to decrease flow until the safe flow rate for that level in the reservoir is reached. The safe flow rate for thearterial pump31 at a given venous reservoir level is based on determining the current volume invenous reservoir106, and determining the time it would take to safely stop the arterial pump (i.e., how fast thearterial pump31 can be stopped without emptying the venous reservoir) and determining the maximum operable flow rate where air would be prevented from entering the venousreservoir outlet tubing110 due to vortexing or air entrainment. From the venous reservoir level, the time required to safely stop the arterial pump, and the maximum operable flow rate for a given level, the safe arterial pump flow rate for a given venous reservoir level can be determined.
• The advantage of using this low level slow down technique is that the arterial pump flow rate is reduced depending upon the reservoir level and there are no abrupt stops and starts of the arterial pump. This smoother control helps improve safety with less chance of entraining air into the venous[0413]reservoir outlet tubing110.
• Existing systems that do not have an available continuous level sensor cannot provide an equivalent form of pump slow down at low reservoir levels. A discreet single level sensor, used on some perfusion systems, can only provide a pump shut down at that level, with the possibility of reverting to some sort of oscillation of the pump around that level.[0414]
• Alternatively, a system using two discreet level sensors could be used to provide a form of level control to maintain level between the locations of these two sensors. The control point is then fixed and no advanced slow down of the pump is possible using this configuration as described above but the arterial pump flow could be increased or reduced to keep the venous reservoir level essentially between the two discrete level sensors.[0415]
• 18. Auto Arterial Line Clamp With Arterial Pump Stop[0416]
• The automatic arterial line clamp with arterial pump stop procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0417]user interface50 will result in the automatic open or closearterial line clamp92 ifarterial pump31 is started or stopped. As will be appreciated, the automatic line clamp procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• This protocol may automatically close the[0418]arterial line clamp92 inarterial line122 whenarterial pump31 is stopped. This prevents draining the patient through the under occluded pump or possibly drawing air through the cannula purse strings ifarterial pump31 is stopped. Conversely,arterial line clamp92 inarterial line122 may open whenarterial pump31 is started.
• 19. Auto Venous Line Clamp With Arterial Pump Stop[0419]
• The automatic venous line clamp with arterial pump stop procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0420]user interface50 will result in the automatic open or close ofvenous line clamp46 ifarterial pump31 is started or stopped. As will be appreciated, the automatic venous line clamp procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• This protocol may automatically close[0421]venous line clamp46 invenous line104 whenarterial pump31 is stopped. This prevents exsanguination of the patient or overflowing thevenous reservoir106 ifarterial pump31 was stopped andvenous line clamp46 was left open. Conversely,venous line clamp46 invenous line104 may open whenarterial pump31 is started.
• 20. Automatic Cardioplegia Delivery[0422]
• The automatic cardioplegia delivery procedures herein described below, initiated and/or enabled by contacting graphic buttons (not shown) on[0423]user interface50 will result in the automatic control of cardioplegia circuit pumps and valves to facilitate delivery of cardioplegia delivery solutions. As will be appreciated, the automatic cardioplegia delivery procedures will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the cardioplegia delivery parameters by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• In one automatic cardioplegia delivery procedure, the[0424]cardioplegia patient valve96 and pre-selectedcrystalloid solution valve99 can be automatically opened when delivery begins (i.e., when cardioplegia pumps35 and or36 are operated) and both thecardioplegia patient valve96 and the pre-selectedcrystalloid solution valve99 can be automatically closed when delivery stops (i.e., when cardioplegia pumps35 and36 are stopped).
• In another cardioplegia automated feature, the user can pre-select different ratios for each of the cardioplegia crystalloid[0425]bags136. During cardioplegia delivery,control unit10 will automatically invoke the pre-selected ratio for the respectivecrystalloid bag136 selected for delivery to the patient.
• Additionally, cardioplegia may be automatically delivered to the patient by either volume delivery (i.e., where a pre-selected bolus volume is delivered to the patient and when the pre-selected volume is delivered, cardioplegia delivery is terminated) or time delivery (i.e., where a cardioplegia bolus is delivered for a pre-selected amount of time and at the end of the pre-selected time, cardioplegia delivery is terminated) or cardioplegia may be delivered manually where the user manually starts cardioplegia until a volume or time has expired and whereby the user manually terminates cardioplegia delivery.[0426]
• Additionally, cardioplegia[0427]crystalloid valves99 can be alternately opened and closed while operatingcrystalloid pump36 to allow variable concentration, fixed dilution delivery. The firstcrystalloid valve99 is opened to draw in a specific volume of crystalloid solution containing a first set of constituent ingredients. Then thesecond valve99 is opened to draw in a second specific volume of crystalloid solution second set of constituent ingredients. Typically, the two crystalloid solutions contain one or more different constituent ingredients whereby the mixing of the two crystalloid solutions at the pre selected proportions will yield the desired concentrations for cardioplegia delivery. The proportion of the volumes drawn from eachcrystalloid bag136 determines the resultant crystalloid constituent concentration(s).
• 21. Vacuum Assisted Venous Drainage (VAVD) Feedback/Control[0428]
• During vacuum assisted venous drainage the vacuum is used to augment the venous return from the patient to ensure there is adequate flow from the patient to maintain the patient on bypass. When flow rates are reduced during the procedure while moving or filling the heart, at the end of the procedure, or any other reason, the vacuum may not be necessary to maintain flow and may create unsafe vacuum levels on circuit components which may cause air to enter the patient circuits.[0429]
• The automatic vacuum assisted venous drainage (VAVD) feedback/control procedure, initiated and/or enabled by contacting a graphic button (not shown) on[0430]user interface50 will result in the automatic control of the venous reservoir vacuum pump or pressure regulator to prevent adverse effects of vacuum on various circuit components. As will be appreciated, the automatic vacuum assisted venous drainage (VAVD) feedback/control procedure will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps.
• To prevent the possibility of negative effects from the vacuum, such as creating a negative pressure acting on the oxygenator membrane and drawing air across membrane into the blood lines, the vacuum can be reduced or stopped through control of a vacuum regulator (not shown) or vacuum pump (not shown) as the[0431]arterial pump31 flow is reduced. Once the system detects thearterial pump31 is slowing down, the vacuum can be reduced to maintain the level in the reservoir. This control method is similar to venous reservoir level control with vacuum as previously described herein.
• Additionally, if[0432]arterial pump31 is stopped the venous reservoir vacuum can be turned off to ensure negative pressure is not applied to the oxygenator or other circuit elements that may not operate properly under negative pressure. In addition to turning the vacuum offcontrol unit10 can also vent the venous reservoir to atmosphere to quickly relieve the vacuum in the venous reservoir through the operation of a vacuum regulator or valve (not shown).
• Additionally, if positive pressure is created in the venous reservoir for example due to a malfunction of a passive pressure relief valve, the positive pressure can be automatically released by the vacuum regulator or valve (not shown) to prevent pressure build up inside the venous reservoir as the pressure exceeds a predetermined value.[0433]
• 22. Automatic Hemoconcentration[0434]
• The automatic hemconcentration procedures herein described below, initiated and/or enabled by contacting graphic buttons (not shown) on[0435]user interface50 will result in the automatic control of hemoconcentrator pumps and valves to facilitate hemoconcentration. As will be appreciated, the automatic hemoconcentration delivery procedures will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the hemoconcentration parameters by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50.
• A two pump hemoconcentration system as described previously with respect to FIG. 3B uses a[0436]blood inflow pump37 to the hemoconcentrator and a blood outflow pump38 from the hemoconcentrator. It has a pressure monitor86 on the hemoconcentrator blood inlet. The pressure sensor monitors the inlet pressure to ensure the pressure does not exceed a predetermined value where an alarm would occur onuser interface50 and/or both the inflow and outflow pumps could be slowed or stopped. There is also avalve39 on the waste line which is closed during a portion of the priming sequence to prevent the prime solution from being passed through the hemoconcentrator and later opened to allow priming across the hemoconcentrator membrane or the valve could be used to provide a restriction on the hemoconcentrator effluent line to reduce effluent flow. Effluent rate and volume could be precisely controlled and determined by controlling the inflow and outflow pump flow rates. The inflow pump flow rate would be greater than the outflow pump flow rate to ensure air is not drawn into the hemoconcentrator circuit across the hemoconcentrator membrane. The effluent rate or ultrafiltrate rate equals the difference between inflow and outflow blood pump rates. Thecontrol unit10 could automatically operate both pumps at respective flow rates to deliver a user selected effluent rate or a user selected effluent volume in a user selected period of time. A scale could be added on the ultrafiltrate waste bag to weigh the effluent to determine the effluent volume.
• Alternatively, the outflow pump could be replaced with a variable restrictor valve (not shown) on the blood out flow line from the hemoconcentrator to change the transmembrane pressure (TMP) which is the driving force of the effluent across the hemoconcentrator membrane. Restricting the valve would increase TMP, subsequently increasing effluent rate and opening the valve would decrease TMP, subsequently decreasing effluent rate.[0437]
• Additionally, a hematocrit sensor (not shown) could be added in the circuit to measure the hematocrit at the outlet of the hemoconcentrator. The[0438]control unit10 could use the outlet hematocrit information and the inlet hematocrit information as measured athematocrit sensor85 or only the hemoconcentrator outlet hematocrit to feedback to and automatically adjust the hemoconcentrator inlet and outlet flow rate to yield a user selected hematocrit of the blood exiting the hemoconcentrator.
• 23. Correct Pump Load and Circuit Test[0439]
• This is a series of automatic tests performed by[0440]control unit10 in conjunction withdisposable assembly100 to determine if the pump headers are loaded properly, if the suction, vent and cardioplegia pumps are fully occluded, and if the arterial pump is overoccluded or underoccluded.
• The automatic pump load and circuit test procedures herein described below, may be automatically initiated during or after disposable load and/or priming will result in the automatic operation of any pump or valve to test the disposable assembly for proper loading and or function. As will be appreciated, the automatic pump load and circuit test procedures will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the user settable pump load and circuit test parameters by contacting graphic buttons (not shown) and/or adjusting[0441]knob52 onuser interface50.
• After loading[0442]disposable assembly100 oncontrol unit10 the suction and vent pumps can be automatically operated to test for correct loading or for leaks in their respective circuits. The patient lines170,172 and186 of these circuits are sealed by connection to plugs or some other connector or connectors that seal the ends oflines170,172, and186. The sealing may occur during assembly ofdisposable assembly100 or the lines could be clamped by the user during the test. The test is performed by operating the two suction pumps and vent pump at a predetermined or user selected speed or flow rate over a predetermined or user selected time period. As the pumps are operated a vacuum is generated in the suction and vent circuits and measured atpressure sensors40,42, and44 until a predetermined pressure is reached where the respective pumps are stopped. If a positive pressure is generated this indicates thepump tubing lines178,180, and190 are probably loaded incorrectly (i.e., reversed) and an alarm occurs advising the user of the condition and any appropriate checks or corrective actions that should occur. If the predetermined pressure cannot be reached during the predetermined test time period this indicates a leak exists in the circuit and an alarm occurs advising the user of the test failure which may include advisory messages in checking for the leak or resolution of the problem. If the predetermined pressure is reached the pumps are stopped and a pressure decay test is performed which monitors the pressure atsensors40,42, and44 and if a predetermined pressure loss over a predetermined time occurs a leak may exist in the circuit and an alarm occurs advising the user of the test failure and any appropriate checks or corrective actions that should occur. If the pressure atsensors40,42, and44 reach the predetermined pressure limit and no significant pressure decay occurs, the circuit is not leaking, the pump tubing has been loaded correctly and the pump is fully occlusive on the pump tubing.
• A similar test is performed on the cardioplegia circuit. For the cardioplegia circuit the[0443]cardioplegia patient valve96 is closed and the pumps (35,36) are operated at a predetermined flow one pump at a time which creates a positive pressure in the circuit to a predetermined pressure as measured atpressure sensor18. If the predetermined pressure cannot be reached during the predetermined test time period this indicates a leak exists in the circuit and an alarm occurs advising the user of the test failure which may include advisory messages in checking for the leak or resolution of the problem. If the predetermined pressure is reached the pumps are stopped and a pressure decay test is performed which monitors the pressure atsensor18 and if a predetermined pressure loss over a predetermined time occurs a leak may exist in the circuit and an alarm occurs advising the user of the test failure and any appropriate checks or corrective actions that should occur. If the pressure at18 reaches the predetermined pressure limit and no significant pressure decay occurs, the circuit is not leaking, the pump tubing has been loaded correctly and the pump is fully occlusive on the pump tubing. This test is repeated for the second cardioplegia pump. The test is performed one cardioplegia pump at a time because the two pumps share the same outlet connection which if the two pumps are operated simultaneously they may mask a small leak.
• The arterial-venous circuit (A-V circuit) could be checked in a similar manner as herein described once the arterial circuit has been primed. The circuit requires priming because air alone would not hold pressure since the pressure would leak across the oxygenator membrane. The test would be conducted in a similar manner as described herein with similar alarm messages.[0444]
• Alternatively, a pressure sensor (not shown) could be added to the A-V circuit on the outlet of the[0445]arterial pump31 between the arterial pump and theoxygenator112 and a valve (not shown) could be added and positioned downstream of the pressure sensor just described. Using this pressure sensor and valve, a similar circuit pressure test as previously described herein for the cardioplegia pumps could be performed to check for circuit leaks, correct loading of the tubing line and pump occlusion in the A-V circuit.
• After auto prime, the system may be checked for leaks by closing various valves, and operating various pumps in various combinations and monitoring respective pressures and pressure decay rates and providing alarms advising the user of circuit or equipment problems if the predetermined pressure limits are not reached or the pressure decay rates exceeded.[0446]
• Additionally, by pressurizing the priming solution in the oxygenator to a predetermined value, leaks in the membrane can be detected with the[0447]liquid leak detector366 shown on FIG. 26 as fluid would transverse a leaky oxygenator membrane at a predetermined pressure.
• 24. Arterial Pump Occlusion Setting Assist[0448]
• The automatic pump occlusion setting assist procedures herein described below, initiated and/or enabled by contacting the graphic “check occlusion” button on[0449]user interface50 will result in the automatic control ofarterial pump31 andvalves92,405 and406 while monitoring pressure atpressure sensor14 to aid in setting the arterial pump occlusion. As will be appreciated, the automatic pump occlusion setting assist procedures will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the user settable parameters by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50. The occlusion check normally occurs after priming but could occur after loadingdisposable assembly100 and before prime.
• After initiation of the automatic pump occlusion setting assist, arterial[0450]patient line valve92, and purgevalves405,406 are closed andarterial pump31 is operated at a predetermined speed for a predetermine time. If the arterial pump outlet pressure as measured atpressure sensor14 exceeds a predetermined pressure value, the pump is stopped and purgevalves405 and/or406 are opened to release the pressure and the occlusion is determined to be over occluded. The user is advised throughuser interface50 of the overoccluded condition and the user is instructed to reduce the occlusion by a predetermined amount and to repeat the test by contacting the check occlusion button (#) onuser interface50. If the predetermined pressure value is not reached, the average pressure is calculated. If the average pressure is greater than a second predetermined pressure value, the user is instructed to reduce the occlusion by a predetermined amount and to repeat the test by contacting the check occlusion button onuser interface50. If the average pressure is less than a third predetermined pressure value, the user is instructed to increase the occlusion by a predetermined amount. If the average pressure is between the second and third pressure values, the occlusion setting is determined to be acceptable and the user is advised of that onuser interface50. The occlusion test is repeated until the pressure is in the predetermined acceptable range or the user ends the test.
• A polynomial is used to determine the occlusion adjustment amount for both reducing or increasing occlusion for an over pressure condition or under pressure condition respectively.[0451]
• Alternatively, a method of measuring occlusion is to close the[0452]arterial line valve92 and thepurge valves405 and406, then operatearterial pump31 until a predetermined pressure has been reached. The arterial pump is then stopped and the pressure decay (i.e., pressure drop over a period of time) is determined by recording the measured pressure atpressure sensor14 at predetermined time intervals. A decay rate of a predetermined range of values would result in an acceptable occlusion. A decay rate exceeding the predetermined decay rate range of values would indicate an underocclusion setting and the user would be instructed to increase occlusion as described herein above. A decay rate less than the predetermined decay rate range of values would indicate an over occlusion setting and the user would be instructed to decrease occlusion as described herein above.
• 25. Arterial Pump Occlusion Setting Methods Using the Cardioplegia Blood Pump.[0453]
• The automatic pump occlusion setting assist procedures herein described below, initiated and/or enabled by contacting a graphic “check occlusion” button on[0454]user interface50 will result in the automatic control ofcardioplegia blood pump34 andvalves92,405 and406 while monitoring pressure atpressure sensor14 to aid in setting the arterial pump occlusion. As will be appreciated, the automatic pump occlusion setting assist procedures will be controlled in accordance with predetermined protocols stored in memory, and will entail automated steps. The user would select the user setable parameters by contacting graphic buttons (not shown) and/or adjustingknob52 onuser interface50. The occlusion check normally occurs after priming but could occur after loadingdisposable assembly100 and before prime.
• The[0455]cardioplegia blood pump34 can be operated in reverse, pumping fluid backwards through the under-occluded arterial pump, while monitoring the arterial line pressure as measured atpressure sensor14 and with arterialpatient valve92,purge valves405 and406 all closed. The flow rate and pressure generated would indicate the occlusion as in a similar manner as previously described herein.
• Alternatively, the cardioplegia blood pump can be operated in the forward direction, with the arterial pump pumping at a predetermined RPM and the arterial outlet line clamped. The speed of the cardioplegia blood pump can be varied to maintain a constant pressure in the arterial line as measured at[0456]pressure sensor14. The difference between the predicted arterial pump flow at full occlusion and the cardioplegia pump flow rate would be the leakage rate due to under-occlusion. (A positive pressure must be maintained to prevent air passing across the oxygenator membrane.)
• The description provided above is strictly for exemplary purposes. Numerous modifications, extensions and adaptations of the present invention will be apparent to those skilled in the art upon consideration, and are intended to be within the scope of the present invention.[0457]

Claims (10)

What is claimed is:

1. A disposable cartridge for use in an extracorporeal blood perfusion system having a cardiopulmonary circuit for receiving venous blood from a patient, oxygenating the blood and returning the oxygenated blood to the patient, a cardioplegia circuit for delivering a cardioplegia solution to the patient, and a suction circuit for withdrawing blood or fluids from the patient or surgical site, the perfusion system having a control unit for controlling the flow of fluids in one or more of the circuits, the disposable cartridge comprising:

a housing defining a plurality of internal passageways, a first internal passageway being configured for connection to the cardiopulmonary circuit, a second internal passageway being configured for connection to the cardioplegia circuit and a third internal passageway being configured for connection to the suction circuit.

2. The disposable cartridge ofclaim 1 further comprising:

a filter configured for filtering fluid flowing through at least one of the plurality of internal passageways.

3. The disposable cartridge ofclaim 1 further comprising:

a bubble trap configured for removing bubbles from fluid in at least one of the plurality of internal passageways.

4. The disposable cartridge ofclaim 1 wherein the housing comprises a first rigid portion connected to a second flexible portion.

5. The disposable cartridge ofclaim 4 wherein the first portion comprises a translucent material configured to allow viewing of fluid in the internal passageways.

6. The disposable cartridge ofclaim 1 further comprising at least one valve interconnected to at least two of the plurality of internal passageways, the valve being configured for selectively preventing fluid flow in at least one of the plurality of internal passageways.

7. The disposable cartridge ofclaim 1 wherein the housing defines a plurality of fluid inlet ports and outlet ports.

8. The disposable cartridge ofclaim 1 wherein the housing further defines an internal reservoir fluidly connected to at least one of the internal passageways.

9. The disposable cartridge ofclaim 1 further comprising a sample port configured for withdrawing a fluid sample from at least one of the plurality of internal passageways.

10. The disposable cartridge ofclaim 4 wherein the control unit of the perfusion system includes at least one fluid pressure sensor and wherein the disposable cartridge further includes at least one pressure sensing station connected to at least one of the plurality of internal passageways, the pressure sensing station being configured to interface with the pressure sensor on the control unit through the flexible portion of the housing.

Images